Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (3616 companies, A–Z).
Cincinnati Financial posted investor presentation slides on November 9, 2026 for use from November 10, 2026. The slides show third-quarter 2026 EPS of $2.96 versus $7.11 in 3Q25, while non-GAAP operating income was $443 million compared with $449 million, and the combined ratio rose to 90.9%. The company said its year-to-date value creation ratio of 5.8% was below its 10% to 13% long-term target.
3Q26 EPS of $2.96 per share versus $7.11 per share in 3Q25
Non-GAAP operating income of $443 million versus $449 million in 3Q25
Combined ratio of 90.9%, 2.7 percentage points higher than 3Q25, including 7.0 points from higher catastrophe losses
YTD 9-30-26 value creation ratio of 5.8%, below the 10% to 13% target; P&C net written premiums grew 4%
Somnigroup released an updated investor presentation on November 9, 2026, alongside its third-quarter 2026 results. Third-quarter net sales rose 10.8% to $2,351 million, and adjusted EPS rose to $1.04 from $0.95, but GAAP net income fell 7.8% to $164 million and GAAP EPS fell to $0.74 from $0.83. The company's 2026 outlook calls for adjusted EPS of $2.90 at the midpoint and sales of approximately $8.65 billion.
Q3 2026 net sales were $2,351 million, up from $2,123 million in Q3 2025
Q3 2026 GAAP EPS was $0.74, down from $0.83; adjusted EPS was $1.04, up from $0.95
Q3 2026 adjusted EBITDA was $448 million, up from $419 million
2026 outlook: adjusted EPS of $2.90 at the midpoint and sales of approximately $8.65 billion
Fervo Energy reported third-quarter 2026 results, with net income of $11.7 million driven largely by a $29.9 million tax benefit and an $11.8 million non-cash swap gain, while operating loss widened to $43.7 million from $13.7 million a year earlier. The company lowered its expected second-half 2026 capital spending to $700 million to $750 million from $850 million to $900 million, and said Cape Google 400 commercial operation dates are unchanged, which matters for shareholders weighing construction costs and timing.
Q3 2026 net income of $11.7 million, versus a net loss of $15.8 million in Q3 2025; the release cites $15.4 million of interest income and two non-recurring items
Q3 2026 operating loss of $43.7 million; general and administrative expense rose to $39.4 million from $27.4 million in Q2 2026
Second-half 2026 capital expenditure outlook cut to $700 million to $750 million from $850 million to $900 million, with no change to expected commercial operation dates
Signed a 15-year take-or-pay power purchase agreement with Google for 396 megawatts, with first power expected mid-2028
Safe Harbor reported third-quarter 2026 revenue of $1.95 million, up 6.5%, while swinging to a net loss of approximately $979,000 from net income a year earlier that included a $3.34 million debt extinguishment gain. The company also disclosed a nonbinding term sheet with Opifex Media Inc. under which Opifex security holders would own about 85% of the combined company, and the company's common share count rose sharply after Series B conversions, which shareholders should weigh against these results.
Q3 2026 revenue was $1.95 million, up from $1.83 million; net loss was approximately $979,000, or $0.95 per share, versus net income of approximately $180,000 in Q3 2025.
Nonbinding term sheet with Opifex Media Inc. signed October 23, 2026; Opifex holders would own approximately 85% of the combined company's fully diluted shares, with the Safe Harbor share adjustable from 12.5% to 17.5%.
Series B conversion price reset to $0.1210 on October 22, 2026; common shares outstanding rose from 1,028,702 on September 30 to 132,248,520 on November 6, 2026.
Nasdaq granted an additional period through April 19, 2027 to regain compliance with the $1 minimum bid price; cash was $4.4 million at September 30, 2026, and the filing includes a going concern disclosure.
OPAL Fuels reported third quarter 2026 revenue of $79.5 million, down 5% from a year earlier, while Adjusted EBITDA rose 32% to $26.7 million and net income was $1.7 million versus a $1.9 million loss. The company now expects 2026 RNG production to be modestly below its guidance range and expects full-year Adjusted EBITDA at the lower end of its guidance range, which it maintained, so shareholders face weaker production expectations even as profit measures improved.
Q3 2026 revenue was $79.5 million, down 5% from $83.4 million in Q3 2025; nine-month revenue was $236.3 million, down 5%.
Q3 2026 Adjusted EBITDA was $26.7 million, up from $20.2 million; net income was $1.7 million versus a $1.9 million loss; basic and diluted EPS was $(0.03), unchanged year over year.
Company now expects 2026 RNG production to be modestly below its guidance range; 2026 Adjusted EBITDA guidance was maintained, with results expected at the lower end of the range.
Three new RNG projects with about 2.0 million MMBtu of annual design capacity are expected to begin commercial operations over 2027.
Quanterix reported third-quarter 2026 revenue of $35.0 million, up 6.3% from the second quarter but down from $40.2 million a year earlier, and a net loss of $21.6 million, compared with $33.5 million a year earlier. The company narrowed its 2026 total revenue outlook to $142-146 million, which gives shareholders a clearer range for the full year.
Q3 2026 revenue of $35.0 million, compared with $40.2 million in Q3 2025 and up 6.3% from Q2 2026.
Net loss of $21.6 million, or $0.46 per share, compared with a net loss of $33.5 million, or $0.73 per share, a year earlier.
2026 total revenue outlook narrowed to $142-146 million; adjusted gross margin expectation of 48-50% unchanged; year-end cash expected at about $70 million with no debt.
Cash, cash equivalents, marketable securities and restricted cash totaled $80.7 million at September 30, 2026.
Uniti Group reported third quarter 2026 revenue of $848.1 million, up from $722.6 million a year earlier, but posted a net loss of $244.5 million, compared with net income of $1,608.9 million in the prior-year quarter that included a $1,685.4 million gain on settlement of preexisting relationships. Adjusted EBITDA was $289.3 million, down from $327.8 million, and the company raised its full-year 2026 revenue outlook to $3.665 billion to $3.695 billion while projecting a net loss of $590 million to $620 million.
Third quarter revenue of $848.1 million, up from $722.6 million in the same quarter of 2025
Net loss of $244.5 million, versus net income of $1,608.9 million in the prior-year quarter, which included a $1,685.4 million settlement gain
Adjusted EBITDA of $289.3 million, down from $327.8 million a year earlier
2026 outlook: revenue of $3.665 billion to $3.695 billion, net loss of $590 million to $620 million, and Adjusted EBITDA of $1.46 billion to $1.49 billion
Turning Point Brands reported third-quarter 2026 results, with net sales up 27.0% to $151.1 million, driven by growth in its Modern Oral products. Net income attributable to the company fell 81.4% to $3.9 million, and diluted EPS was $0.19 versus $1.13 a year earlier, as sales and marketing spending increased. The company reaffirmed its full-year 2026 guidance, which it had last updated on September 21, 2026.
Net sales rose 27.0% to $151.1 million; Modern Oral net sales rose 102.9% to $74.4 million.
Net income attributable to Turning Point Brands fell 81.4% to $3.9 million; diluted EPS was $0.19 versus $1.13.
Adjusted EBITDA fell 41.3% to $18.4 million, including increased sales and marketing investments.
Full-year 2026 guidance reaffirmed: Modern Oral net sales of $260-$270 million and Adjusted EBITDA of $70-$80 million.
WhiteHorse Finance reported third quarter 2026 results for the period ended September 30, 2026, with net investment income of $4.4 million, or $0.207 per share, down from $4.7 million in the prior quarter. Net asset value per share rose to $11.82 from $11.77, and the board declared a $0.25 per share distribution payable January 6, 2027, while the adviser agreed to lower its incentive fee rate to 17.50%.
Net investment income was $4,439 thousand, or $0.207 per share, down 5.2% from $4,681 thousand in Q2 2026; core net investment income rose 2.7% to $4,806 thousand, or $0.224 per share
Net asset value per share increased to $11.82 from $11.77; net realized losses were $3,631 thousand
Quarterly distribution of $0.25 per share payable January 6, 2027 to holders of record as of December 21, 2026; a special distribution of $0.17 per share is payable December 10, 2026
Adviser voluntarily reduced the incentive fee rate from 20.00% to 17.50% for the quarter ending December 31, 2026
CECO Environmental reported third-quarter 2026 revenue of $404.4 million, up 105% from a year earlier, following its June 1, 2026 acquisition of Thermon. The company swung to a GAAP net loss of $2.0 million, though non-GAAP net income rose to $34.3 million. It raised its full-year 2026 orders and free cash flow conversion outlook, kept its revenue and Adjusted EBITDA outlook unchanged, and introduced a 2027 outlook.
Q3 2026 revenue was $404.4 million, up 105%; GAAP net loss was $2.0 million versus net income of $1.5 million a year earlier.
Non-GAAP diluted EPS was $0.60 versus $0.26; Adjusted EBITDA was $70.1 million, up 202%.
2026 orders outlook raised to exceed $2.5 billion from at least $2.0 billion; free cash flow conversion raised to about 100% of Adjusted EBITDA from at least 55%.
2026 revenue ($1.300 billion to $1.375 billion) and Adjusted EBITDA ($200 million to $225 million) outlooks were maintained; 2027 revenue outlook is $2.1 billion to $2.3 billion.
RadNet reported third-quarter 2026 revenue of $638.3 million, up 22.1%, and Adjusted EBITDA of $105.0 million, up 23.8%, both described as records. GAAP net income attributable to common stockholders fell to $4.2 million, or $0.05 per diluted share, from $5.4 million, or $0.07, a year earlier. The company raised its 2026 Imaging Center guidance for revenue, Adjusted EBITDA and free cash flow, and raised Digital Health Adjusted EBITDA guidance.
Q3 2026 revenue was $638.3 million, up from $522.9 million; Adjusted EBITDA was $105.0 million, up from $84.9 million.
GAAP net income attributable to RadNet common stockholders was $4.2 million ($0.05 per diluted share) versus $5.4 million ($0.07) in Q3 2025; adjusted diluted EPS was $0.30 versus $0.24.
Imaging Center guidance raised to $2,385-$2,435 million revenue, $350-$363 million Adjusted EBITDA and $120-$130 million free cash flow.
Digital Health Adjusted EBITDA fell 11.8% to $3.0 million in Q3; cash was $750.6 million at September 30, 2026, and the pending ONRAD acquisition was referenced.
ImmunityBio reported third-quarter 2026 net product revenue of $48.7 million, up 53% from a year earlier, and nine-month net product revenue of $143.6 million, up 92%. Net loss attributable to common stockholders rose to $184.6 million for the quarter from $67.3 million, mainly due to non-cash fair value changes in a related-party convertible note, warrant and derivative liabilities after a higher common stock price, along with higher interest expense and operating costs.
Q3 2026 net product revenue was $48.7 million, up 53% year-over-year; nine-month net product revenue was $143.6 million, up 92%.
Q3 2026 net loss attributable to common stockholders was $184.6 million, versus $67.3 million in Q3 2025; basic loss per share was $0.17 versus $0.07.
Nine-month net loss attributable to common stockholders was $1.0 billion, versus $289.5 million a year earlier.
Cash, cash equivalents and marketable securities totaled $334.3 million as of September 30, 2026.
Tonix Pharmaceuticals reported third-quarter 2026 net product revenue of $17.2 million, up from $3.3 million a year earlier, with TONMYA contributing $15.0 million. The net loss available to common stockholders widened to $53.3 million from $32.0 million, as research and development and selling, general and administrative expenses rose sharply. The company said its cash resources will meet its requirements into the early third quarter of 2027, a timeline shareholders will weigh against the larger losses.
Net product revenue was $17.2 million versus $3.3 million a year earlier; TONMYA net revenue was $15.0 million, up 37% from the second quarter.
Net loss available to common stockholders was $53.3 million, or $2.89 per share, compared with $32.0 million, or $3.59 per share, a year earlier.
R&D expenses were $25.8 million and SG&A expenses were $45.6 million, compared with $9.3 million and $25.7 million a year earlier.
Cash and cash equivalents were about $163 million as of September 30, 2026; the company expects them to fund operations into the early third quarter of 2027.
Roivant reported results for the quarter ended September 30, 2026, its first quarter with sales of LISRAYA (brepocitinib), which launched in August 2026. Revenue rose to $35.1 million from $1.6 million a year earlier, but the net loss attributable to Roivant widened to $191.6 million, or $0.27 per share, from $113.5 million, or $0.17, partly due to $95.9 million of distributions tied to Moderna settlement proceeds.
LISRAYA generated net product revenue of $31.0 million in its first 5 weeks of launch following FDA approval in August 2026.
Net loss attributable to Roivant was $191.6 million, or $0.27 per share, versus $113.5 million, or $0.17 per share, a year earlier.
Net loss included $95.9 million of distributions on Genevant equity awards tied to Moderna settlement proceeds.
Cash, cash equivalents and marketable securities were $4.2 billion as of September 30, 2026.
Powerfleet reported fiscal second-quarter 2027 revenue of $115.7 million, up 4% year over year, but its net loss attributable to common stockholders widened to $6.9 million from $4.3 million. The company said it has agreed in principle to a device financing facility with Rand Merchant Bank, subject to definitive documentation, and affirmed its fiscal 2027 revenue and adjusted EBITDA guidance.
Revenue rose to $115.7 million from $111.7 million, while gross margin fell to 53% from 56%.
Profit from operations was $1.4 million, compared with $4.2 million a year earlier, per the statement of operations.
Agreed in principle to a device financing facility with Rand Merchant Bank; terms remain subject to definitive documentation.
Fiscal 2027 guidance affirmed: revenue of $468 million to $473 million and adjusted EBITDA of $111 million to $114 million.
Superior Group reported third quarter 2026 net sales of $146.0 million, up 5% from $138.5 million a year earlier, but net income fell to $2.6 million, or $0.17 per diluted share, from $2.7 million, or $0.18. The company narrowed its full-year 2026 net sales and adjusted EPS forecasts by raising the low end of each range, which signals somewhat firmer expectations for shareholders.
Q3 2026 net sales of $146.0 million, up 5% from $138.5 million in Q3 2025
Net income of $2.6 million, or $0.17 per diluted share, versus $0.18 a year earlier
Adjusted EBITDA of $6.7 million, down from $7.5 million; CEO cited incremental charges tied to the Healthcare Apparel strategic shift
2026 net sales outlook narrowed to $578.0 million to $585.0 million; adjusted EPS outlook narrowed to $0.60 to $0.66
Hain Celestial reported fiscal first quarter 2027 results for the quarter ended September 30, 2026, with net sales down 29% to $260 million and a net loss of $11 million, narrowed from $21 million a year earlier. The company said final regulatory approvals were received in early November 2026 for the sale of its International business to AURELIUS, but a condition requiring a credit agreement amendment by October 12, 2026 was not satisfied, and discussions on a path forward continue.
Net sales were $260 million, down 29% year over year; organic net sales fell 7%.
Net loss was $11 million, or $0.12 per diluted share, versus $21 million, or $0.23, a year earlier; adjusted EBITDA was $18 million versus $20 million.
Final required regulatory approvals for the International sale to AURELIUS were received in early November 2026.
The credit agreement amendment condition due October 12, 2026 was not satisfied; total debt was $586 million at quarter end.
Ceva reported third quarter 2026 results, with total revenue of $29.1 million, up 2% from a year earlier, and a GAAP net loss of $2.3 million, down from $2.5 million. The GAAP operating loss widened to $3.5 million from $2.1 million, and gross margin fell, so profitability trends are mixed.
Total revenue was $29.1 million, up 2% year over year; royalty revenue was $12.7 million, up 18% sequentially.
GAAP diluted loss per share was $0.08, compared with $0.10 a year earlier; non-GAAP diluted earnings per share was $0.13, versus $0.11.
GAAP operating loss was $3.5 million, compared with $2.1 million, and GAAP gross margin was 85%, compared with 88%.
The CFO said a significant multi-year connectivity agreement expected in the third quarter was signed in early fourth quarter 2026.
AMG reported third-quarter 2026 results. Consolidated revenue rose to $595.2 million from $528.0 million, but diluted EPS fell to $6.64 from $6.87, and the prior-year quarter included affiliate transaction gains. Non-GAAP Economic EPS rose to $9.50 from $6.10, and the company repurchased $400 million of stock and declared a $0.01 per share dividend.
Diluted EPS was $6.64 versus $6.87 a year earlier; net income (controlling interest) was $173.3 million versus $212.4 million.
Economic EPS (non-GAAP) was $9.50 versus $6.10; Adjusted EBITDA (controlling interest) was $353.7 million versus $250.9 million.
Consolidated revenue was $595.2 million versus $528.0 million; AUM was $973.9 billion at September 30, 2026, with net client cash flows of $20.7 billion in the quarter.
Quarterly dividend of $0.01 per share is payable December 3, 2026 to holders of record on November 19, 2026.
Village Farms reported third-quarter 2026 consolidated net sales of $66.9 million, nearly unchanged from $66.7 million a year earlier, with record cannabis sales of $55.0 million offset by lower cannabis gross margin of 48% versus 55%. Net income attributable to shareholders was $10.0 million, or $0.08 per share, compared with $10.2 million a year earlier, and adjusted EBITDA from continuing operations fell to $18.2 million from $20.7 million.
Consolidated net sales were $66.9 million for Q3 2026, versus $66.7 million in Q3 2025.
Cannabis net sales rose 3% to $55.0 million, while cannabis gross margin was 48%, down from 55%, which the company attributed mainly to a softer Canadian spot trim market.
Net income attributable to shareholders was $10.0 million, or $0.08 per share, versus $10.2 million in the prior-year quarter.
The company closed the quarter with $80 million in cash and a net cash position of $41 million.
Praxis Precision Medicines reported a third-quarter 2026 net loss of $94.2 million, up from $73.9 million a year earlier, while its loss per share narrowed to $3.23 from $3.36 on a larger share count. The company had $1.3 billion in cash and investments at September 30, 2026, which it says funds operations into 2028, and it has two FDA applications under review with target action dates of December 27, 2026 and January 29, 2027.
Net loss was $94.2 million for Q3 2026 versus $73.9 million for Q3 2025; loss per share was $3.23 versus $3.36.
General and administrative expenses rose to $42.7 million from $12.6 million, mainly on $17.2 million in higher personnel costs and $9.4 million in higher professional expenses.
Cash, cash equivalents and marketable securities were $1.3 billion at September 30, 2026, which the company says funds operations into 2028.
FDA target action dates are December 27, 2026 for relutrigine and January 29, 2027 for ulixacaltamide; Investor Day is November 12, 2026.
KKR reported third quarter 2026 results, with GAAP net income attributable to common stockholders of $1.1 billion, up from $860 million a year earlier, and diluted EPS of $1.19 versus $0.90. Total revenues fell to $4.56 billion from $5.53 billion, largely in the Insurance segment, while the company said fee related earnings, total operating earnings and adjusted net income per share were all records on a quarterly and trailing twelve-month basis.
GAAP net income to common stockholders was $1.1 billion in Q3 2026 versus $860 million in Q3 2025; diluted EPS was $1.19 versus $0.90.
Total revenues were $4.56 billion versus $5.53 billion a year earlier; Insurance revenues were $2.80 billion versus $3.78 billion.
Fee Related Earnings were $1.3 billion, up 27% year over year; adjusted net income was $1.6 billion ($1.78 per adjusted share), up 29%.
The board approved a $500 million increase to the share repurchase program on November 6, after $567 million of repurchases from June 30 through November 4.
Target Hospitality reported third quarter 2026 revenue of $129.1 million, up 30% from a year earlier, and Adjusted EBITDA of $34.2 million, up 59%. The company also posted a net loss of $9.2 million, or $0.09 per share, compared with a loss of $0.8 million, or $0.01 per share, a year earlier. It reaffirmed its full-year 2026 outlook, which covers revenue of $435 to $445 million and Adjusted EBITDA of $105 to $115 million.
Q3 2026 revenue was $129.1 million, up from $99.4 million in Q3 2025.
Workforce Hospitality Solutions revenue rose to $79.5 million from $36.8 million, with 6,222 average utilized beds.
Full-year 2026 outlook was reaffirmed: revenue of $435 to $445 million and Adjusted EBITDA of $105 to $115 million.
Ferguson reported net sales of $9.0 billion for the quarter ended September 30, 2026, up 9.5%, with reported diluted EPS of $3.08, down 4.9%, and adjusted EPS of $3.43, up 7.9%. The company raised its 2026 net sales growth guidance to about 7% from mid-single digits, citing year-to-date performance and the FloWorks acquisition, while buybacks are paused and net debt to adjusted EBITDA rose to 1.7x from 1.0x.
Q3 net sales $9.0 billion, up 9.5%, including 7.0% organic growth
Reported diluted EPS $3.08, down 4.9%; adjusted diluted EPS $3.43, up 7.9%
2026 net sales growth guidance raised to about 7% from mid-single digits; adjusted operating margin guidance 9.6%-9.8%
Quarterly dividend of $0.89 payable January 8, 2027; share repurchases paused after FloWorks, with buybacks expected to resume as leverage falls
CNH reported third-quarter 2026 revenues of $4.35 billion, roughly flat year over year, and reported net income of $35 million, down from $67 million, after a $156 million non-cash deferred tax valuation allowance charge in Brazil. Adjusted net income rose to $205 million, helped by $109 million in pre-tax IEEPA tariff refunds, and the company raised its 2026 adjusted EPS and free cash flow guidance, which matters to shareholders because the results mix a weaker reported profit with improved adjusted and outlook figures.
Reported net income was $35 million, or $0.02 per diluted share, versus $67 million, or $0.06, in Q3 2025.
Adjusted net income was $205 million versus $109 million; adjusted diluted EPS was $0.16 versus $0.08.
Consolidated revenues were $4.35 billion, down 1% from $4.40 billion a year earlier.
2026 adjusted diluted EPS guidance was raised to $0.44 to $0.48 from $0.41 to $0.46, and Industrial Activities free cash flow guidance to $300 million to $450 million from $200 million to $400 million.
Somnigroup reported third-quarter 2026 net sales up 10.8% to $2.35 billion, including $372.6 million from Leggett & Platt after its August 26, 2026 acquisition. GAAP diluted EPS fell 10.8% to $0.74, while adjusted EPS rose 9.5% to $1.04, and the company revised its full-year 2026 adjusted EPS guidance to $2.85 to $2.95. The company also declared a quarterly dividend of $0.17 per share.
Q3 net sales rose 10.8% to $2,350.8 million; GAAP net income fell 7.8% to $163.5 million
Full-year 2026 adjusted EPS guidance revised to a range of $2.85 to $2.95, about 7% above 2025 adjusted EPS at the midpoint
Quarterly dividend of $0.17 per share, payable December 7, 2026, to holders of record on November 23, 2026
Sable Offshore reported third quarter 2026 revenue of $154.4 million, up 13% from the prior quarter, with average net sales volumes up 29% to about 27 thousand barrels of oil per day. The company said its sole downstream crude purchaser halted purchases in early October 2026, which it describes as creating near-term working capital constraints, and it is evaluating a bulk sale of crude held in inventory. Shareholders face a mix of stronger sales and a disruption to cash flow that the company is still working to resolve.
Q3 2026 total revenue of $154.4 million, up 13% quarter over quarter; cash and cash equivalents of $38.0 million at quarter end
Crude oil sales halted by sole downstream purchaser in early October 2026 for storage tank maintenance; sales to three additional Los Angeles-area refineries began in early November 2026
Platform Hondo final MMA inspections and initial production scheduled for November 2026, with all producing wells forecast online in December 2026 at about 10,000 gross barrels of oil per day
Sold 16,110,711 shares under its at-the-market program in Q3 2026 at an average of about $4.75 per share; no ATM sales in Q4 2026 to date
Berkshire Hathaway reported third-quarter 2026 net earnings of $22.1 billion, down from $30.8 billion a year earlier, as investment gains fell to $9.4 billion from $17.3 billion. For the first nine months, net earnings rose to $57.9 billion from $47.8 billion, and operating earnings rose to $37.0 billion from $34.3 billion, so the quarterly decline and the year-to-date gain point in different directions for shareholders.
Q3 2026 net earnings were $22.1 billion versus $30.8 billion in Q3 2025; Q3 operating earnings were $12.7 billion versus $13.5 billion.
First nine months 2026 net earnings were $57.9 billion versus $47.8 billion in the same period of 2025; operating earnings were $37.0 billion versus $34.3 billion.
Berkshire acquired about $9.6 billion of treasury shares in Q3 2026 and about $14.4 billion in the first nine months.
The results were released November 7, 2026 and furnished as Exhibit 99.1 to a Form 8-K dated November 9, 2026.
EVgo reported third quarter 2026 results, with total revenue down 1% year-over-year while charging network revenue rose 29%. The net loss widened to $49.2 million, and the company updated its full-year 2026 guidance. The board also received a non-binding, unsolicited proposal from LS Power to acquire the shares it does not own for $2.00 per share in cash, which could affect shareholders if pursued.
Total Q3 2026 revenue was $91.4 million, down 1% from $92.3 million, while charging network revenue rose 29% to $71.8 million.
Q3 2026 net loss was $49.2 million, compared with $28.4 million in Q3 2025; adjusted EBITDA loss narrowed to $3.5 million from $5.0 million.
Updated 2026 guidance: total revenue of $375 million to $400 million and adjusted EBITDA loss of $15 million to $30 million.
On November 2, LS Power Equity Advisors proposed to acquire EVgo's Class A shares not already owned by LS Power for $2.00 per share in cash; a special committee of independent directors is reviewing it.
TEN Holdings reported third-quarter 2026 revenue of $640,000, up 17.9% from a year earlier, but its net loss rose 87.9% to $3,734,000. The loss reflects a $1.8 million write-off of previously capitalized service contracts and about $0.5 million in legal expenses, which the company calls non-recurring. Shareholders also face a change in finance leadership, as Ian M. Lawson became interim chief financial officer effective September 30, 2026.
Revenue was $640,000 versus $543,000 a year earlier; gross margin fell to 59.2% from 74.6%.
Net loss was $3,734,000, or $(0.31) per share, compared with $1,987,000, or $(0.84) per share, in the third quarter of 2025.
The company cited a $1.8 million write-off of capitalized service contracts and about $0.5 million in legal expenses.
Ian M. Lawson was appointed interim chief financial officer, effective September 30, 2026.
CPS Technologies reported fiscal third-quarter 2026 revenue of $8.9 million, up from $8.8 million a year earlier, with gross margin of 20.9% versus 17.1%. For the nine months, the company posted an operating loss of $423,415 compared with operating income of $542,659 a year earlier, and it signed a lease for an 80,000-square-foot facility in Attleboro, Massachusetts.
Q3 revenue of $8.9 million versus $8.8 million in the prior-year quarter
Q3 gross profit of $1.9 million, or 20.9% of revenue, versus 17.1% a year earlier
Q3 operating income of $357,747 versus $276,082; nine-month operating result was a loss of $423,415 versus income of $542,659
Company signed a long-term lease for an 80,000-square-foot facility in Attleboro, Massachusetts, about twice its current size
Star Holdings reported a third-quarter net loss attributable to common shareholders of $45.1 million, or $3.74 per share, for the quarter ended September 30, 2026. The loss reflects a non-cash mark-to-market adjustment of $53.1 million on its roughly 13.5 million Safehold (SAFE) shares, which reduced per-share earnings by $4.40. The company also raised cash through asset sales and cut its margin loan balance roughly in half, which matters to shareholders because the company says it plans to realize value mainly through asset sales and active asset management.
Q3 2026 net loss attributable to common shareholders: $45.1 million, or $3.74 per share
Non-cash SAFE adjustment of $53.1 million reduced earnings per share by $4.40
Sold municipal debt securities portfolio for $50.2 million, with a $4.5 million gain
Sold Coney Island land parcel for $20.0 million with a $4.7 million profit; margin loan reduced from $94.5 million to $46.5 million
Kestrel Group reported a third-quarter 2026 net loss of $16.4 million, or $2.09 per share, on total revenues of $4.8 million. Program Services fee income rose 203% year over year to $2.9 million, while the Legacy Reinsurance segment posted a $6.4 million underwriting loss. Management is targeting about $5 million in run-rate expense savings over the next year.
Q3 2026 net loss of $16.4 million, or $2.09 per share; total revenues of $4.8 million
Program Services fee income of $2.9 million, up 203% year over year; premium produced of $121.2 million, up 132%
Legacy Reinsurance segment underwriting loss of $6.4 million, including a $6.5 million loss in the Diversified business
Targeting approximately $5 million in run-rate expense savings over the next twelve months
DTE Energy Company furnished unaudited financial statements for its indirect subsidiary, DTE Gas Company, for the quarter ended September 30, 2026. DTE Gas reported a net loss of $29 million for the third quarter and net income of $176 million for the first nine months of 2026. These results provide transparency into the operating performance and financial condition of the utility subsidiary for shareholders.
DTE Gas reported operating revenues of $211 million for the third quarter ended September 30, 2026, compared to $207 million for the same period in 2025.
Net loss for the third quarter of 2026 was $29 million, improving from a net loss of $36 million in the third quarter of 2025.
For the nine months ended September 30, 2026, net income was $176 million, compared to $175 million for the first nine months of 2025.
Global Self Storage reported third-quarter 2026 results for the period ended September 30, 2026. Revenue rose 0.6% to $3.2 million and FFO and AFFO grew, but net income fell 16.0% to $417,000 and same-store occupancy slipped to 92.9% from 93.2% a year earlier. The company maintained its $0.0725 quarterly dividend and reported capital resources of about $24.3 million.
Total revenues rose 0.6% to $3.2 million; net income fell 16.0% to $417,000, or $0.04 per diluted share.
FFO rose 5.8% to $1.1 million ($0.09 per diluted share) and AFFO rose 4.7% to $1.1 million ($0.10 per diluted share); both are non-GAAP measures.
Same-store NOI fell 0.6% to $2.0 million, with cost of operations up 2.5% to $1.3 million.
Same-store occupancy was 92.9% as of September 30, 2026, versus 93.2% a year earlier; the quarterly dividend stayed at $0.0725 per share.
Ring Energy reported third-quarter 2026 results on November 5, 2026, with revenue down about 2% from the second quarter to $102.3 million, mainly on lower realized oil prices. The company posted a net loss of $16.6 million, or $0.06 per diluted share, compared with net income of $64.8 million in the prior quarter, which included a $41.0 million unrealized derivative loss this quarter, while adjusted net income rose 14% to $27.3 million.
Revenue $102.3 million, down about 2% from $104.7 million in Q2 2026; realized oil price $83.72 per barrel, down about 12%
Net loss $16.6 million ($0.06 per diluted share) versus net income $64.8 million in Q2 2026; includes a $41.0 million unrealized derivative loss
Adjusted net income $27.3 million ($0.10 per diluted share), up 14%; adjusted EBITDA $57.1 million, up 5%
Revolving credit facility borrowings reduced by $10.0 million to $350.0 million at September 30, 2026; Q4 2026 oil guidance 12,900 to 13,500 Bo/d
U.S. Physical Therapy reported third-quarter 2026 net revenue of $223 million, up 13% year over year, but posted a loss of $1.04 per share, compared with earnings of $0.48 per share a year earlier, mainly due to a non-cash contingent earn-out charge and noncontrolling interest effects described by the company. Management reaffirmed 2026 adjusted EBITDA guidance of $102 million to $106 million and declared a quarterly dividend of $0.46 per share.
Q3 2026 net revenue was $223 million, up 13% from Q3 2025; adjusted EBITDA was $28 million versus $24 million.
Q3 2026 loss per share was $1.04 versus earnings of $0.48 per share; adjusted earnings per share was $0.80 versus $0.66.
Full-year 2026 adjusted EBITDA guidance of $102 million to $106 million was reaffirmed.
Quarterly dividend of $0.46 is payable December 11, 2026, to holders of record on November 16, 2026.
NI Holdings reported third-quarter 2026 net income of $5.5 million, or $0.27 per basic share, compared with a net loss of $1.7 million, or $(0.08) per share, a year earlier. The improvement came mainly from a lower combined ratio, but gross premiums written fell 7.2% as the company continues to exit the Non-Standard Auto segment, which matters to shareholders because premium volume is shrinking.
Net income was $5.5 million for the quarter versus a $1.7 million loss in Q3 2025; nine-month net income was $18.2 million versus a $7.3 million loss.
Combined ratio improved to 93.6% from 109.1%, driven mainly by favorable prior-year loss reserve development in Non-Standard Auto.
Gross premiums written fell 7.2% to $54.3 million and net premiums earned fell 8.6% to $65.8 million; Non-Standard Auto premiums declined 100.2%.
Net investment income was $2.7 million, down 10.7%, as maturities and sales funded operating cash needs in Non-Standard Auto.
Hawaiian Electric Industries reported third quarter 2026 GAAP net income of $35 million, or $0.20 per diluted share, up from $31 million, or $0.18, a year earlier. Non-GAAP Core net income fell to $23 million, or $0.13 per share, from $33 million, or $0.19, as the company absorbed $14 million of storm costs and a $51 million Pacific Current impairment, offset in GAAP results by gains tied to its American Savings Bank stake.
Total third quarter revenues were $1.01 billion, compared with $791 million in the third quarter of 2025.
GAAP diluted EPS was $0.20 versus $0.18; Core diluted EPS was $0.13 versus $0.19.
The quarter included $64 million of pre-tax gains related to HEI's American Savings Bank investment and a non-cash $51 million pre-tax asset impairment at Pacific Current.
Hawaiian Electric recorded $14 million of incremental pre-tax storm costs for August and September, and its Core net income was $28 million versus $40 million a year earlier.
BOK Financial furnished a November 2026 investor presentation summarizing its third-quarter 2026 results. Net income was $159.9 million, or $2.64 per diluted share, down from $176.5 million, or $2.92, in the second quarter but up from $140.9 million, or $2.22, a year earlier. The presentation also shows the 2026 full-year outlook as of October 20, 2026, which shareholders can compare with the company's prior guidance.
Q3 2026 net income was $159.9 million, or $2.64 per diluted share, versus $176.5 million, or $2.92, in Q2 2026 and $140.9 million, or $2.22, in Q3 2025.
Q2 2026 results included a net gain from the exchange of Visa B shares and a loss from repositioning the available-for-sale securities portfolio; excluding these, Q2 net income would have been $156.5 million, or $2.59 per diluted share.
Net interest margin rose 9 basis points to 3.00%, and period-end loans grew $646 million, or 2.4%, to $27.7 billion.
The 2026 outlook as of October 20, 2026 shows net interest income of $1.43 billion to $1.44 billion and a provision expense below $10 million.
National HealthCare Corporation reported third-quarter 2026 net operating revenues of $407,971,000, up 6.6%, and adjusted net income of $28,154,000, up 13.8%. GAAP net income attributable to NHC fell to $13,637,000 from $39,239,000, and the company tied the adjusted gain mainly to 2026 facility acquisitions.
Net operating revenues were $407,971,000 for the quarter ended September 30, 2026, versus $382,661,000 a year earlier.
GAAP diluted EPS was $0.85 versus $2.50; adjusted diluted EPS was $1.76 versus $1.58.
Adjusted net income rose to $28,154,000 from $24,744,000, driven by the June 1, 2026 acquisition of five skilled nursing facilities and the July 1, 2026 acquisition of real estate from National Health Investors.
The GAAP decline reflects a $17,599,000 unrealized loss on marketable equity securities in the quarter, which the company excludes from adjusted results.
Minerva Neurosciences reported GAAP net income of $100.7 million for the quarter ended September 30, 2026, compared with a net loss of $2.7 million a year earlier. The company said the result was driven by a $109.6 million non-cash gain from changes in the fair value of its warrant liability, and excluding that gain and stock-based compensation, its adjusted net loss widened to $5.6 million from $2.5 million. For shareholders, the operating loss grew as research and development and general and administrative spending rose, and cash and equivalents fell to about $77.0 million.
GAAP net income of $100.7 million, or $1.94 per basic share and $(0.19) per diluted share, for the three months ended September 30, 2026, versus a net loss of $2.7 million a year earlier.
Non-cash warrant liability gain of $109.6 million; adjusted net loss was $5.6 million versus $2.5 million in the prior-year quarter.
R&D expense was $5.2 million versus $0.9 million, and G&A expense was $4.3 million versus $1.9 million.
Cash, cash equivalents, marketable securities and restricted cash were about $77.0 million at September 30, 2026, down from $82.4 million at December 31, 2025.
Immunocore reported third-quarter 2026 KIMMTRAK net revenue of $102.2 million, down from $103.7 million a year earlier, and a net loss of $14.2 million ($0.28 per share) versus a $0.2 million loss in Q3 2025. The company attributed the revenue decline mainly to U.S. wholesaler stocking in Q2 2026 and one extra week of U.S. sales in Q3 2025, and said underlying growth was about 10%. Nine-month revenue rose to $324.8 million from $295.5 million, and the nine-month net loss narrowed to $2.1 million from $5.5 million.
Q3 2026 net revenue was $102.2 million, versus $103.7 million in Q3 2025; the company cited about 10% underlying growth after adjusting for U.S. items
Q3 2026 net loss was $14.2 million ($0.28 per share), compared with $0.2 million ($0.00 per share) a year earlier
Nine-month 2026 revenue was $324.8 million, up from $295.5 million; nine-month net loss was $2.1 million ($0.04 per share)
Cash, cash equivalents and marketable securities were $901.3 million at September 30, 2026; the company expects about $120 million in sales-related rebate payments in Q4 2026
United Bancorp (UBCP) reported third-quarter 2026 net income of $1.4 million, or $0.25 per diluted share, down 27.4% from $1.9 million, or $0.34, a year earlier. Management attributed the decline to a $2,953,000 charge-off of a single commercial credit, which raised the quarter's provision for credit losses to $2,421,000. Total revenue rose 15.16% and pre-provision net revenue rose 66.45%, but the one-time loan loss reduced earnings for shareholders.
Q3 2026 net income of $1,401,000 and diluted EPS of $0.25, versus $0.34 in Q3 2025
Nine-month net income of $5,407,000 and diluted EPS of $0.94, versus $0.99 a year earlier
Single commercial borrower charge-off of $2,953,000 drove a Q3 provision for credit losses of $2,421,000
Non-GAAP pre-provision net revenue of $3,490,000 for Q3, up $1,393,000 year over year, including a $560,000 securities gain
Plains reported third-quarter 2026 results on November 6, 2026. Net income attributable to PAA fell to $363 million from $441 million, and diluted net income per common unit turned to a loss of $0.06 from a profit of $0.55, while adjusted EBITDA attributable to PAA rose 6% to $711 million on revenues of $15.2 billion. Management said the company is on track to meet full-year 2026 adjusted EBITDA guidance attributable to PAA of $2.880 billion, plus or minus $50 million, so unitholders see a mixed quarter: the operating measure grew, but reported profit declined.
Net income attributable to PAA was $363 million, down 18% from $441 million a year earlier.
Diluted net loss per common unit was $0.06, compared with earnings of $0.55 per unit in the third quarter of 2025.
Adjusted EBITDA attributable to PAA rose 6% to $711 million; revenues were $15.2 billion versus $11.6 billion.
Full-year 2026 adjusted EBITDA guidance attributable to PAA of $2.880 billion plus or minus $50 million was reaffirmed as on track, and a quarterly distribution of $0.4175 per unit was paid.
Plains All American reported third-quarter 2026 results on November 6, 2026. Revenue and adjusted EBITDA attributable to PAA rose, but net income attributable to PAA fell 18% and the per-unit result turned to a loss of $(0.06), which the company tied in part to a $358 million impact from repurchasing Series A preferred units. Management said it is on track to meet full-year 2026 adjusted EBITDA guidance of $2.880 billion, plus or minus $50 million.
Net income attributable to PAA was $363 million versus $441 million a year earlier; diluted net income/(loss) per common unit was $(0.06) versus $0.55.
Revenues were $15.173 billion versus $11.578 billion, and adjusted EBITDA attributable to PAA was $711 million, up 6%.
Full-year 2026 adjusted EBITDA attributable to PAA guidance of $2.880 billion plus or minus $50 million was reaffirmed as on track.
Distribution declared was $0.4175 per unit, up 10% from $0.3800 a year earlier.
DarkHorse Technologies reported third-quarter 2026 revenue of $3.0 million, up from $2.6 million a year earlier, and a net loss of $5.8 million, wider than the $4.2 million loss in the third quarter of 2025 but narrower than the $13.8 million loss in the second quarter of 2026. The company says the revenue gain mainly reflects the Cathedra Bitcoin operations acquired June 1, 2026, and the results have limited comparability with the prior year.
Revenue was $3.0 million in Q3 2026, versus $2.5 million in Q2 2026 and $2.6 million in Q3 2025.
Net loss was $5.8 million, or $0.65 per share, versus $4.2 million, or $1.49 per share, in Q3 2025.
Cash and cash equivalents were $8.8 million at September 30, 2026, up from $2.8 million at June 30, 2026.
Contracted power roughly doubled to about 100 MW after a 50 MW contract with Hopkinsville Electric System signed September 30, 2026.
Calumet reported third-quarter 2026 results, with sales of $1.68 billion, up from $1.08 billion a year earlier. Net income fell to $273.3 million from $313.4 million, and basic earnings per share were $2.91 versus $3.61, after non-cash derivative and RINs-related charges. Adjusted EBITDA rose to $322.0 million from $69.6 million, and the company said it has retired about $265 million of debt since July.
Q3 2026 sales of $1.68 billion vs. $1.08 billion in Q3 2025; net income of $273.3 million vs. $313.4 million
Basic EPS of $2.91 vs. $3.61 a year earlier; net income attributable to common shareholders of $256.4 million
Adjusted EBITDA of $322.0 million vs. $69.6 million; Adjusted EBITDA with Tax Attributes of $347.2 million vs. $92.5 million
Non-cash items included a $113.8 million unrealized derivatives loss and $176.7 million of RINs-related items; $150 million of 2028 Notes were redeemed on October 25, 2026
Dauch reported third quarter 2026 results with sales of $2.91 billion, up from $1.51 billion a year earlier, mainly because of the Dowlais acquisition. The company swung to a net loss attributable to Dauch of $45.3 million, or $(0.19) per share, compared with net income of $9.2 million, or $0.07 per share, a year earlier. It raised its full-year sales outlook but lowered its full-year Adjusted EBITDA range, so the results and guidance point in different directions for shareholders.
Third quarter sales were $2.91 billion versus $1.51 billion in Q3 2025; the Dowlais acquisition was the primary driver of year-over-year changes.
Net loss attributable to Dauch was $45.3 million, or $(0.19) per share, versus net income of $9.2 million, or $0.07 per share, in Q3 2025.
Adjusted EBITDA was $358.5 million, or 12.3% of sales, versus $195.7 million, or 13.0% of sales, a year earlier.
Full-year 2026 Adjusted EBITDA outlook was lowered to $1.35–$1.375 billion from $1.36–$1.425 billion, while the sales outlook was raised to $10.8–$10.875 billion from $10.6–$10.8 billion.
Under Armour reported revenue of $1.24 billion for the quarter ended September 30, 2026, down 7% from a year earlier, while its net loss narrowed to $425 thousand from $18.8 million. The company raised its fiscal 2027 GAAP operating income outlook to $99 million to $119 million, but cut its expected gross margin improvement, which shareholders should weigh against the lower sales.
Q2 net revenues were $1.24 billion, down 6.9% from $1.33 billion; North America fell 7% and international fell 7%.
Q2 GAAP operating income was $15 million, versus $17 million a year earlier; adjusted operating income was $25 million.
Fiscal 2027 GAAP operating income outlook was raised to $99 million to $119 million, from $96 million to $116 million.
Expected gross margin improvement was lowered to 170 to 220 basis points from 220 to 270, citing fuel, freight and foreign exchange costs.
MSG Rangers reported its first quarter results as a standalone company after its October 26, 2026 spin-off from MSG Knicks. Revenue rose 3% to $14.1 million, but the operating loss widened to $23.6 million and the net loss per share was $1.39, versus $0.89 a year earlier.
Revenues of $14.1 million for the quarter ended September 30, 2026, up $0.4 million, or 3%, from $13.7 million
Operating loss of $23.6 million, up $10.7 million from $12.8 million, driven mainly by higher SG&A and direct operating expenses
Net loss of $16.9 million, or $1.39 per share, compared with a net loss of $10.8 million, or $0.89 per share, a year earlier
Net cash used in operating activities was $71.2 million for the quarter, compared with $5.1 million a year earlier
MSG Knickerbockers Corp. reported results for the fiscal first quarter ended September 30, 2026, which include the New York Rangers business it spun off on October 26, 2026. Revenues rose 15% to $45.5 million and operating loss narrowed to $25.5 million, but net loss widened to $31.1 million, or $1.29 per share, from $8.8 million, or $0.37 per share, a year earlier. For shareholders, the top-line and operating results improved while the bottom-line loss grew.
Revenues of $45.5 million, up $6.0 million, or 15%, from the prior-year quarter, led by $3.1 million higher league distributions and $2.6 million higher food, beverage and merchandise sales
Operating loss of $25.5 million, improved $2.0 million, or 7%; adjusted operating loss of $20.0 million, improved $0.8 million, or 4%
Net loss of $31.1 million, or $1.29 per share, versus a net loss of $8.8 million, or $0.37 per share, a year earlier
Cash and cash equivalents fell to $40.0 million at September 30, 2026, from $164.5 million at June 30, 2026, after $146.3 million of cash used in operating activities
Array Digital Infrastructure reported third quarter 2026 results, with total operating revenues from continuing operations rising to $53.9 million from $47.1 million a year earlier. Net income attributable to Array shareholders from continuing operations fell to $69.6 million, or $0.81 per diluted share, from $108.8 million, or $1.25 per share, and the company reaffirmed its 2026 guidance, which it left unchanged.
Total operating revenues from continuing operations were $53.9 million, up from $47.1 million in the third quarter of 2025.
Diluted EPS from continuing operations was $0.81, compared with $1.25 a year earlier.
2026 guidance is unchanged: total operating revenues of $205-$215 million, Adjusted OIBDA of $60-$75 million, Adjusted EBITDA of $220-$235 million, and capital expenditures of $25-$35 million.
TDS said on September 1, 2026 that it is no longer pursuing its non-binding proposal to acquire the Array shares it does not own.
Alpha Metallurgical Resources reported a third-quarter 2026 net loss of $9.3 million, or $0.73 per diluted share, down from a $12.3 million loss in the second quarter but up from $5.5 million a year earlier. The company also issued 2027 operational guidance and said it has committed 3.5 million tons of domestic 2027 sales at an average of $135.48 per ton.
Q3 2026 net loss of $9.3 million ($0.73 per share), versus $12.3 million ($0.96 per share) in Q2 2026 and $5.5 million ($0.42 per share) in Q3 2025
Adjusted EBITDA of $29.4 million, up from $25.6 million in Q2 2026 but down from $41.7 million in Q3 2025
2027 guidance: 14.3 million to 15.7 million total tons shipped and cost of coal sales of $104.00 to $110.00 per ton
Stacker reclaimer at Dominion Terminal Associates damaged in a June storm; replacement expected to take a lengthy time, with insurer discussions ongoing
Sylvamo reported a third-quarter 2026 net loss of $199 million, or $4.98 per diluted share, driven by a $284 million loss from discontinued operations, primarily a noncash impairment tied to its Europe business. Sales from continuing operations of $645 million and adjusted operating earnings of $53 million were both lower than a year earlier but higher than the second quarter. The company also said it entered a put option agreement with Midas Atlantic Partners for a binding offer to acquire its Europe business, which it says would leave Sylvamo more focused on Latin America and North America.
Net sales from continuing operations were $645 million, versus $662 million in Q3 2025 and $614 million in Q2 2026.
Net loss was $199 million ($4.98 per diluted share), including a $284 million loss from discontinued operations.
Adjusted operating earnings were $53 million ($1.33 per diluted share), versus $72 million ($1.79) a year earlier.
Put option agreement with Midas Atlantic Partners for a binding offer to acquire the Europe business; dividend of $0.45 per share was paid Oct. 16.
Anika Therapeutics reported third-quarter 2026 revenue of $30.6 million, up 10% from a year earlier, and a narrower GAAP loss from continuing operations of $0.3 million. It raised the low end of its 2026 total revenue guidance and its 2026 adjusted EBITDA margin guidance, but cut its Commercial Channel growth guidance. In October, the FDA said the Hyalofast application is not approvable, which removes a near-term regulatory path for that product.
Revenue was $30.6 million versus $27.8 million; Commercial Channel rose 17% to $14.0 million and OEM Channel rose 5% to $16.6 million.
GAAP loss from continuing operations was $0.3 million, or $0.02 per diluted share, versus $3.2 million a year earlier; adjusted EBITDA was $5.1 million versus $0.9 million.
2026 total revenue growth guidance is now 6% to 10%, up from 5% to 10%; Commercial Channel guidance was cut to 9% to 13% from 12% to 18%.
In October, the FDA informed Anika that the Hyalofast pre-market approval application is not approvable, primarily based on the clinical data submitted.
Canopy Growth reported fiscal second-quarter 2027 results for the three months ended September 30, 2026, with consolidated net revenue up 22% to C$81.4 million, led by a 141% rise in international cannabis sales. Net loss increased by $35.7 million from the prior-year quarter because of $35.8 million of fair value charges on Canopy USA related assets, and gross margin fell to 29% from 33%. Shareholders get higher sales and a narrower adjusted EBITDA loss, but a larger reported net loss.
Consolidated net revenue was C$81.4 million, up 22%; Cannabis segment revenue was C$66.2 million, up 30%.
International markets cannabis revenue rose 141% to C$12.3 million from C$5.1 million, driven by Germany and Poland.
Net loss rose by $35.7 million, driven by $35.8 million of fair value charges on Canopy USA related assets.
Adjusted EBITDA loss was C$2.9 million, an improvement of C$0.2 million or 6%; Storz & Bickel revenue fell 4% to C$15.1 million.
Treace Medical reported third-quarter 2026 revenue of $48.3 million, down 4% from $50.2 million a year earlier, while its net loss narrowed to $12.6 million from $16.3 million. The company raised its full-year 2026 Adjusted EBITDA outlook to a loss of $1.0 million to $2.0 million, from a prior loss estimate of $3.0 million to $5.0 million, and narrowed its revenue range to $206 million to $210 million.
Q3 2026 revenue was $48.3 million, down 4% from $50.2 million in Q3 2025; the company said bunion kit sales volume excluding stocking distributors grew mid-single digits.
Q3 2026 net loss was $12.6 million, or $(0.19) per share, versus $16.3 million, or $(0.26) per share, a year earlier.
Q3 2026 Adjusted EBITDA was $0.3 million, compared with a loss of $2.6 million in Q3 2025.
Full-year 2026 revenue guidance is $206 million to $210 million, versus the prior $204 million to $212 million; cash usage reduction of about 50% was reiterated.
TeraWulf reported third-quarter 2026 revenue of $76.2 million, up from $50.6 million a year earlier, with HPC lease revenue of $63.0 million. Net income attributable to the company was $709.9 million, driven mainly by a non-cash $728.4 million change in fair value of warrant and derivative liabilities, while operating loss widened to $88.2 million and non-GAAP Adjusted EBITDA was $(12.8) million.
Q3 revenue $76.2 million vs. $50.6 million a year earlier; HPC lease revenue $63.0 million
Net income attributable to TeraWulf $709.9 million, including a $728.4 million warrant fair value gain; operating loss $88.2 million vs. $24.7 million a year earlier
Adjusted EBITDA $(12.8) million vs. $18.1 million a year earlier; $2.4 billion cash, cash equivalents and restricted cash at quarter-end
Charter Communications reported its third-quarter 2026 financial and operating results, highlighted by a pro forma net loss of $2.1 billion driven largely by a $6.3 billion franchise impairment charge. The company also announced a new operating model and a plan to achieve $2 billion in annualized operating expense savings over the next 18 months, alongside the recently completed Cox Communications acquisition.
Pro forma third quarter revenue declined 1.5% year-over-year to $16.5 billion, while actual revenue rose 9.1% to $14.9 billion following the Cox Transactions.
Pro forma net loss attributable to Charter shareholders reached $2.1 billion, primarily due to a $6.3 billion franchise impairment charge.
Charter announced a new plan targeting $2 billion in annualized run-rate operating expense savings over the next 18 months.
Spectrum Mobile added 508,000 pro forma lines in the third quarter, bringing total mobile lines to 13.5 million as of September 30, 2026.
Starwood Property Trust reported a third-quarter GAAP net loss of $389.7 million, alongside Distributable Earnings of $116.8 million, or $0.31 per diluted share. The company invested $3.2 billion during the quarter and repurchased $108 million of its common shares.
GAAP net loss of $389.7 million for the third quarter ended September 30, 2026, including a $336.6 million credit loss provision.
Distributable Earnings of $116.8 million, or $0.31 per diluted share.
Invested $3.2 billion in the quarter, bringing the commercial lending portfolio to a record $17.8 billion.
Repurchased $108 million of common shares and declared a dividend of $0.48 per share.
JBG SMITH reported third-quarter 2026 results, with Core FFO attributable to common shares of $12.7 million, or $0.22 per diluted share, up from $9.1 million, or $0.15, a year earlier. The company also reported a net loss of $82.0 million, or $1.41 per share, compared with a $28.6 million loss a year earlier, and the loss included $69.2 million of impairment losses. For shareholders, core operating earnings improved, but the larger loss reflects write-downs on real estate.
Core FFO was $12.7 million, or $0.22 per diluted share, for the three months ended September 30, 2026, versus $9.1 million, or $0.15, a year earlier.
Net loss was $82.0 million, or $1.41 per diluted share, versus $28.6 million, or $0.48, in the prior-year quarter; impairment losses were $69.2 million.
Same Store NOI at the company's share rose 3.3% to $60.8 million, and the Same Store multifamily portfolio was 94.4% leased as of September 30, 2026.
The Board declared a quarterly dividend of $0.175 per common share, payable November 25, 2026, to holders of record as of November 12, 2026.
Humana reported third-quarter 2026 financial results with GAAP earnings of $1.33 per share and an adjusted loss of $0.70 per share. The company raised its full-year 2026 adjusted EPS guidance to at least $9.50 while also expanding its CenterWell and Medicaid patient footprints.
Reported third-quarter 2026 GAAP EPS of $1.33 and an adjusted loss per share of $0.70.
Raised full-year 2026 adjusted EPS guidance to at least $9.50, up from the prior expectation of at least $9.00.
CenterWell Senior Primary Care grew by 146,800 patients year-to-date, representing a 30 percent increase.
Medicaid membership grew by 103,600 members, or 7 percent, year-to-date.
LCI Industries reported third-quarter 2026 results on a call furnished in an 8-K. Net sales were just under $1 billion, down 4% from a year earlier, while adjusted diluted EPS rose to $2.21 from $1.97 and GAAP diluted EPS was $2.05. The company narrowed its full-year adjusted EPS outlook to $8.25 to $8.50 and said the proposed merger with Patrick Industries remains pending.
Q3 2026 net sales were just under $1 billion, down 4% year over year, mainly due to lower North American RV wholesale shipments.
Adjusted diluted EPS was $2.21 versus $1.97 a year earlier; GAAP net income was $50 million, or $2.05 per diluted share.
Full-year 2026 adjusted EPS range was tightened to $8.25 to $8.50; adjusted revenue is expected at $3.9 billion to $4 billion.
The company said it declined a Monomoy Capital proposal because its board judged it not superior to the proposed merger with Patrick Industries.
VAALCO reported a third-quarter 2026 net loss of $39.8 million ($0.38 per diluted share), compared with net income of $42.4 million in the second quarter, mainly due to $34.7 million of unrealized hedging losses. Net revenue and Adjusted EBITDAX both rose from the second quarter, and the company gave fourth-quarter 2026 sales volume and capital spending guidance.
Q3 2026 net loss of $39.8 million ($0.38 per diluted share) versus Q2 2026 net income of $42.4 million
Net revenue of $147.0 million, up 9% from Q2 2026; Adjusted EBITDAX up 30% to $71.1 million
Q4 2026 guidance: NRI sales volumes of 20,800 to 22,600 BOPD and capital expenditures of $55 million to $75 million
Quarterly dividend of $0.0625 per share payable December 22, 2026; conference call November 6, 2026 at 8:00 a.m. Central Time
Athene Holding furnished its third-quarter 2026 financial supplement, showing a GAAP net loss available to common stockholder of $1,158 million, compared with net income of $1,223 million a year earlier. Spread related earnings, the company's management measure, fell 3% to $844 million, but rose 7% to $909 million excluding notable items, and the filing says the GAAP loss was tied to large investment and market risk benefit swings. Shareholders face a larger GAAP loss and lower stockholders' equity, while the underlying spread measure was mixed.
GAAP net loss available to Athene common stockholder of $1,158 million in 3Q'26, versus net income of $1,223 million in 3Q'25
Spread related earnings of $844 million, down 3% year over year; excluding notable items, $909 million, up 7%
Total revenues of $3,065 million versus $7,998 million a year earlier, with investment related losses of $3,418 million
Total Athene Holding stockholders' equity was $13,413 million at September 30, 2026, down from $20,492 million at December 31, 2025
Friedman Industries reported record second-quarter results for the period ended September 30, 2026, with net earnings of $15.6 million on net sales of $286.8 million, versus $2.2 million and $152.4 million a year earlier. The company also recorded a $14.6 million hedging charge in the quarter, of which $9.8 million is unrealized, a charge close in size to the quarter's net earnings.
Net earnings of $15.6 million ($2.19 diluted EPS) vs. $2.2 million ($0.32) in the prior-year quarter
Net sales of $286.8 million, up from $152.4 million; sales volume of about 219,500 tons, up 23%
$14.6 million hedging charge in the quarter, including $9.8 million unrealized on open metal positions
Management expects third-quarter sales volume consistent with seasonal trends and sequential margin improvement
MSC Income Fund reported third quarter 2026 total investment income of $35.5 million, up $0.2 million from a year earlier, while net investment income fell 13% to $14.4 million, or $0.32 per share. Net increase in net assets from operations dropped 32% to $18.1 million, and net asset value rose to $16.56 per share from $16.51 at June 30, 2026, and $15.85 at December 31, 2025. Nick Meserve is set to become CEO effective November 9, 2026, as previously announced in June.
Net investment income was $14.4 million, or $0.32 per share, versus $16.6 million, or $0.35 per share, in Q3 2025.
Total investment income was $35.5 million, compared with $35.4 million in Q3 2025.
Net asset value was $16.56 per share as of September 30, 2026, up from $16.51 at June 30, 2026.
Nick Meserve will transition to CEO effective November 9, 2026, with Dwayne L. Hyzak continuing as Executive Chairman.
SUI Group Holdings reported third-quarter 2026 net income of $47.7 million, or $0.59 per diluted share, compared with a net loss of $44.3 million a year earlier. The result was driven mainly by $82.7 million in unrealized gains on digital assets, while revenue fell, and the company's revenue and other income excluding investment gains and losses was $557,000 against $2.6 million a year earlier.
Q3 2026 net income was $47.7 million ($0.59 per diluted share), versus a net loss of $44.3 million ($0.72 per share) in Q3 2025.
Digital asset results included $82.7 million in net unrealized gains and $28.0 million in realized losses, which the company said mainly reflect U.S. GAAP treatment and SUI's market price.
Total revenue and other income excluding investment gains and losses fell to $557,000 from $2.6 million, mainly due to lower legacy loan income and lower SUI staking revenue.
As of November 2, 2026, the company held 109,290,995 SUI, including 6,000,000 SUI loan receivables, and reported an mNAV of 0.72x.
Hyster-Yale reported third-quarter 2026 revenue of $827.4 million, down 15% from a year earlier but up 2% from the prior quarter, with a net loss of $14.9 million compared with a $2.3 million loss in Q3 2025. The company expects substantially stronger Q4 2026 results, with adjusted net income returning to positive, and launched cost-reduction programs targeting at least $100 million of annual savings at maturity, with implementation costs of at least $50 million.
Q3 2026 revenue was $827.4 million, down from $979.1 million in Q3 2025 and up from $812.9 million in Q2 2026.
Net loss was $14.9 million, or $0.83 per diluted share, versus a $2.3 million loss in Q3 2025; adjusted diluted loss was $0.77 per share.
Lift Truck bookings rose 45% year over year to $550 million, and unit backlog reached $1.6 billion.
New programs target at least $100 million of annual cost savings at maturity in 2029, with implementation costs of at least $50 million; 2026 capital expenditures are expected at $50 million to $60 million.
Cryoport reported third-quarter 2026 revenue of $50.2 million, up 14% from a year earlier, and raised its full-year 2026 revenue guidance to $197 million to $199 million. The company still posted a wider net loss attributable to common stockholders of $12.9 million, or $0.25 per share, compared with a $8.9 million loss, or $0.18 per share, in the prior-year quarter.
Q3 2026 total revenue was $50.2 million, up 14% year over year; Life Sciences Services rose 18% to $28.6 million.
Full-year 2026 revenue guidance was raised to $197 million to $199 million.
Q3 2026 net loss attributable to common stockholders was $12.9 million, or $0.25 per share, versus $8.9 million, or $0.18 per share, in Q3 2025.
Adjusted EBITDA from continuing operations was $1.1 million for Q3 2026, compared with a negative $0.6 million a year earlier.
Gyre Therapeutics reported third-quarter 2026 revenue of $32.9 million, up 1% from $32.7 million a year earlier, but swung to a net loss of $2.5 million from net income of $1.9 million. The company affirmed its full-year 2026 revenue guidance of $100.5 million to $111.0 million, while nine-month results showed a larger loss and lower revenue, which matters to shareholders weighing the cost of the Cullgen acquisition and clinical spending.
Q3 2026 revenue was $32.9 million versus $32.7 million in Q3 2025; ETUARY sales were $31.4 million.
Q3 GAAP basic EPS was $(0.04), compared with $0.01 a year earlier.
Nine-month net loss was $35.3 million versus net income of $4.6 million; nine-month revenue was $86.5 million versus $93.0 million.
Total cash, deposits and certificates of deposit were $98.8 million at September 30, 2026, down from $116.1 million at December 31, 2025.
Camden Property Trust announced its third quarter 2026 operating results, reporting a diluted EPS of $8.71 primarily driven by a gain on the sale of its California portfolio. The company updated its full-year 2026 earnings guidance and adjusted its same-property growth forecasts.
Diluted EPS for 3Q26 was $8.71, compared to $1.00 in 3Q25.
Core FFO per diluted share for 3Q26 was $1.71, compared to $1.70 in 3Q25.
The company sold its California portfolio for approximately $1.6 billion, recognizing a gain of about $1.0 billion.
Full-year 2026 diluted EPS guidance was revised to a range of $9.42 to $9.46.
nLIGHT reported third quarter 2026 revenue of $73.8 million, up 10.5% from a year earlier, with gross margin of 33.1% versus 31.1%, while its GAAP net loss widened to $7.2 million from $6.9 million. For the fourth quarter, it guided to revenue of $84 million to $90 million, but that range excludes about $15 million of product revenue now expected to ship in the first half of 2027 because of supply chain constraints.
Q3 2026 revenue was $73.8 million versus $66.7 million in Q3 2025, and Adjusted EBITDA was $11.05 million versus $7.1 million.
GAAP net loss was $7.2 million, or $0.12 per diluted share, compared with $6.9 million, or $0.14 per share, in Q3 2025.
Fourth quarter 2026 revenue guidance is $84 million to $90 million, with Adjusted EBITDA guided to $12 million to $18 million.
About $15 million of product revenue expected in Q4 2026 is now expected to be delivered in the first half of 2027.
Kingsway reported third quarter 2026 results with consolidated revenue up 4.5% to $38.9 million, driven by a 18.2% rise in KSX revenue to $22.4 million. The company posted a net loss of $3.2 million, wider than the $2.4 million loss a year earlier, and adjusted EBITDA of $2.0 million was slightly below $2.1 million. Shareholders see higher sales but a larger loss and flat adjusted EBITDA, while the company also disclosed organic growth figures for the first time.
Consolidated revenue rose 4.5% to $38.9 million from $37.2 million in the third quarter of 2025.
Net loss was $3.2 million versus $2.4 million a year earlier; adjusted EBITDA was $2.0 million versus $2.1 million.
Extended Warranty revenue fell 9.8% to $16.4 million, reflecting the sale of Trinity Warranty Solutions LLC; excluding Trinity it rose 5.9%.
Total net debt was $60.3 million at September 30, 2026, down from $62.4 million at December 31, 2025.
Neighborhood Intelligence reported third quarter 2026 revenue of $509 million, up 98% year over year, mainly from the acquisitions of Kirkland's and The Container Store. The company also posted a net loss of $26 million, compared with $5 million a year earlier, and gave a 2027 outlook of $2.0 billion to $2.1 billion in consolidated revenue. Revenue growth came from acquisitions, while the larger loss and negative adjusted EBITDA show the company has not yet reached profitability.
Q3 2026 net revenue was $509 million, up from $257 million, with $229 million of the increase from acquired businesses.
Net loss was $26 million, or $0.28 per share, compared with $5 million, or $0.07 per share, a year earlier.
Adjusted EBITDA was negative $26 million, compared with negative $5 million in the prior-year period.
The company expects 2027 consolidated revenue of $2.0 billion to $2.1 billion and gross margins of 33% to 34%.
Power Solutions International reported third quarter 2026 net sales of $202.1 million, down 1% from a year earlier but up 32.5% from the second quarter, and diluted EPS of $1.30 versus $1.20. The company raised its outlook, now expecting second-half 2026 net sales to exceed second-half 2025 net sales, up from its earlier view of roughly flat, and said it is not providing formal full-year guidance. Quarterly operating income of $40.9 million was a record but included a $3.8 million tariff refund that the company says will not recur, and nine-month net income fell 45% to $54.1 million.
Q3 2026 net sales were $202.1 million, down 1% from $203.8 million in Q3 2025; gross margin was 29.7% versus 23.9%.
Net income was $29.9 million, or $1.30 per diluted share, versus $27.6 million, or $1.20, a year earlier; the prior-year period included a $0.30 per share tax benefit.
Second-half 2026 net sales are now expected to exceed second-half 2025 net sales, compared with the earlier expectation of approximately in line.
Total debt fell by $34.9 million during the quarter to $37.7 million, with cash of $72.0 million as of September 30, 2026.
Main Street Capital reported third quarter 2026 results in a press release furnished as Exhibit 99.1 to a Form 8-K. Total investment income rose 2% to $142.5 million, but net investment income fell 3% to $83.8 million ($0.89 per share, down from $0.97), and net assets from operations declined 5%, which shareholders should weigh against the $34.22 per share net asset value, up from $33.92 at June 30, 2026.
Net investment income was $83.8 million, or $0.89 per share, versus $86.5 million, or $0.97 per share, in the third quarter of 2025.
Total investment income was $142.5 million, up 2% from $139.8 million a year earlier.
Net asset value was $34.22 per share at September 30, 2026, up from $33.92 at June 30, 2026, and the company declared a $0.30 per share supplemental dividend payable in December 2026.
Fidelity National Financial reported third quarter 2026 net earnings attributable to common shareholders of $633 million, or $2.37 per diluted share, compared with $358 million, or $1.33 per share, for the third quarter of 2025. Adjusted net earnings attributable to common shareholders were $352 million, or $1.32 per share, compared with $439 million, or $1.63 per share, in the prior year period. The company returned $143 million of capital to shareholders during the quarter through dividends and share repurchases.
Net earnings attributable to common shareholders were $633 million, or $2.37 per diluted share, for the third quarter of 2026.
Adjusted net earnings attributable to common shareholders were $352 million, or $1.32 per share, for the third quarter of 2026.
F&G's assets under management before reinsurance reached $76.2 billion as of September 30, 2026.
FNF returned approximately $143 million to shareholders in the third quarter of 2026 through $138 million of dividends and $5 million of share repurchases.
Saul Centers reported third-quarter 2026 results with total revenue up to $78.4 million from $72.0 million a year earlier, while net income fell to $12.6 million from $14.0 million. Net income available to common stockholders dropped to $6.7 million, or $0.27 per share, from $7.7 million, or $0.32 per share, and funds from operations (FFO) per share held at $0.72. Management attributed $3.7 million of the net income decline to the initial operations of Hampden House, a residential and retail property that opened on October 1, 2025.
Total revenue for the quarter ended September 30, 2026 was $78.4 million, up from $72.0 million.
Net income available to common stockholders was $6.7 million, or $0.27 per basic and diluted share, versus $0.32 a year earlier.
FFO available to common stockholders and noncontrolling interests was $25.9 million, or $0.72 per share, flat with the prior-year quarter.
As of November 2, 2026, 267 of 366 Hampden House residential units (73.0%) were leased and occupied.
F&G Annuities & Life reported third-quarter 2026 net earnings to common shareholders of $736 million, or $5.48 per diluted share, up from $114 million, or $0.85 per share, a year earlier. Adjusted net earnings fell to $96 million, or $0.74 per share, from $165 million, or $1.22 per share, and total revenues declined to $1,131 million from $1,694 million, so the headline measures point in different directions for shareholders.
GAAP net earnings to common shareholders were $736 million ($5.48 per diluted share), including $648 million of net favorable mark-to-market effects excluded from adjusted results
Adjusted net earnings were $96 million ($0.74 per share), versus $165 million ($1.22 per share) in the third quarter of 2025
Assets under management before reinsurance were $76.2 billion as of September 30, 2026, up 7% from a year earlier; net sales were $1.4 billion versus $2.8 billion
Capital returned to shareholders in the first nine months of 2026 totaled $232 million, including $112 million of dividends and $120 million of share repurchases
Axon Enterprise reported third-quarter 2026 revenue of $909 million, an increase of 28% year over year, driven by strong growth in Software & Services. The company also announced a $1.2 billion investment in Skydio, raising its ownership stake to 37% and establishing an exclusive public safety distribution partnership. Net income reached $57 million, recovering from a net loss in the prior-year period.
Q3 2026 total revenue grew 28% year over year to $909 million, with net income of $57 million.
Announced a $1.2 billion investment in Skydio, increasing the ownership stake to 37%.
Full-year 2026 revenue growth is expected to be approximately 30%, reflecting $130 million in excluded Federal Dedrone deployments.
Annual recurring revenue grew 40% year over year to $1.8 billion as of September 30, 2026.
Mattel reported third quarter 2026 net sales of $1,807 million, up 4%, and diluted EPS of $1.23 versus $0.88 a year earlier. The company said the gross margin gain was primarily driven by $88 million of tariff refunds, and its revised 2026 guidance excludes those refunds. The company also named Steve Totzke President and Chief Operating Officer, effective November 11, 2026.
Q3 2026 net sales were $1,807 million, up 4% as reported and 3% in constant currency
Q3 2026 net income was $354 million, an increase of $75 million; diluted EPS was $1.23 versus $0.88
Full-year 2026 adjusted EPS guidance is $1.05 to $1.20 and adjusted operating income guidance is $500 million to $570 million, excluding tariff refunds
Steve Totzke appointed President and COO effective November 11, 2026; Roberto Stanichi resigned as President, Chief Marketing and Brand Officer, effective November 10, 2026
Cloudflare reported fiscal third-quarter 2026 revenue of $782.5 million, up 39% year over year, and non-GAAP net income per diluted share of $0.38, up from $0.27. GAAP net loss widened to $34.1 million from $1.3 million, and the company disclosed restructuring and other charges of $11.0 million for the quarter and $161.7 million for the first nine months. The filing also announced Christian Smith's appointment as President of Revenue.
Q3 revenue of $782.5 million, up 39% year over year; GAAP gross margin 71.2%, down from 74.0%
GAAP net loss of $34.1 million, compared with $1.3 million in Q3 2025; non-GAAP net income of $143.7 million
Q4 2026 guidance: total revenue of $845.0 to $846.0 million and non-GAAP net income per share of $0.43
Christian Smith appointed President of Revenue, effective November 2, 2026
Callaway Golf reported third quarter 2026 net sales of $436.9 million, down 5.6% from a year earlier, while GAAP net income was $45.7 million compared with a net loss of $14.7 million in the prior-year quarter. The company raised its full-year 2026 net sales and Adjusted EBITDA outlook, but still expects fourth-quarter results to be down year over year.
Q3 Adjusted EBITDA was $35.9 million, up 17.3%; GAAP gross margin rose to 51.9%, up about 1,210 basis points.
Full-year 2026 net sales outlook raised to $2.065 billion to $2.078 billion, from $2.045 billion to $2.070 billion.
Full-year 2026 Adjusted EBITDA outlook raised to $272 million to $280 million, from $246 million to $260 million.
Q4 2026 net sales are estimated at $328 million to $341 million, versus $368 million a year earlier.
Fox Factory reported third-quarter fiscal 2026 results, with net sales down 10.1% to $338.4 million and a GAAP net loss of $109.6 million that includes a $121.3 million loss on divestitures. Adjusted EBITDA rose to $50.4 million, but that figure includes about $12 million of IEEPA tariff refunds, and the company updated its fourth-quarter outlook and narrowed its fiscal 2026 adjusted EBITDA range.
Net sales were $338.4 million, down from $376.4 million a year earlier; GAAP net loss attributable to FOX stockholders was $109.6 million, or $2.61 per diluted share, versus a $0.6 million loss a year earlier.
Adjusted EPS was $0.54 versus $0.23, and adjusted EBITDA was $50.4 million versus $44.4 million, including about $12 million of IEEPA tariff refunds.
Total debt fell to $397.4 million from $673.5 million at January 2, 2026, after the Marucci Sports divestiture closed on September 25, 2026.
Fourth-quarter outlook: net sales of $287 million to $313 million and adjusted EBITDA of $25 million to $30 million; fiscal 2026 adjusted EBITDA of $143 million to $148 million excluding tariff refunds.
Willdan reported third-quarter 2026 results for the period ended October 2, 2026, with net revenue up 18.1% to $112.2 million but net income down 13.6% to $11.9 million. The company raised its fiscal 2026 targets and gave preliminary fiscal 2027 targets, and said it closed the Mantis Innovation acquisition, which it called the largest in its history.
Q3 contract revenue $214.5 million, up 17.9%; GAAP diluted EPS $0.76, down 15.6%
Q3 adjusted EBITDA $28.3 million, up 22.4%; adjusted diluted EPS $1.20, down 0.8%
FY2026 targets raised: net revenue $435 million to $445 million; adjusted diluted EPS $5.15 to $5.25
Preliminary FY2027 targets include contract revenue above $1 billion and adjusted EBITDA above $140 million
RenovoRx reported third-quarter 2026 revenue of $1.07 million, up from $266,000 a year earlier, and kept its full-year 2026 revenue guidance of $3.75 million to $4.25 million. The net loss widened to $3.6 million, or $0.08 per share, from $2.9 million, as selling, general and administrative expenses rose to $2.9 million from $1.7 million, so shareholders see faster sales growth alongside higher losses.
Q3 2026 revenue was $1.07 million versus $266,000 in Q3 2025; gross margin was about 82%.
Net loss was $3.6 million ($0.08 per share) versus $2.9 million ($0.08 per share) a year earlier.
Selling, general and administrative expenses were $2.9 million versus $1.7 million, which the company attributed to building commercial infrastructure.
Cash and cash equivalents were $10.4 million at September 30, 2026; the company says cash is sufficient into the second half of 2027.
AMN Healthcare reported third-quarter 2026 revenue of $717.3 million, up 13% from a year earlier, with GAAP diluted EPS of $0.83 versus $0.76 and adjusted diluted EPS of $1.16 versus $0.39. The company guided fourth-quarter revenue to $655 million to $670 million, 10-12% below the prior year, with operating margin of (0.1%) to 0.5%, so shareholders face a sharp expected slowdown after a quarter boosted by labor disruption revenue.
Q3 2026 revenue $717.3 million, up 13% year over year; GAAP net income $33.4 million
GAAP diluted EPS $0.83 vs $0.76 a year ago; adjusted diluted EPS $1.16 vs $0.39
Q3 labor disruption revenue $59 million vs $12 million in Q3 2025
Q4 2026 guidance: revenue $655-670 million, operating margin (0.1%) to 0.5%, labor disruption revenue assumed at $5 million vs $124 million in Q4 2025
Global Net Lease reported third quarter 2026 revenue of $112.9 million and a net loss attributable to common stockholders of $67.1 million, with AFFO of $48.3 million, or $0.22 per share. The company raised the low end of its full-year 2026 AFFO per share guidance to $0.83 from $0.82, for a range of $0.83 to $0.85, and reaffirmed its Net Debt to Adjusted EBITDA range of 6.5x to 6.9x.
Q3 2026 revenue of $112.9 million; net loss attributable to common stockholders of $67.1 million
AFFO of $48.3 million, or $0.22 per share, for the third quarter of 2026
Full-year 2026 AFFO per share guidance now $0.83 to $0.85; gross transaction volume guidance now $750 million to $800 million
Repurchased about 6.6 million shares for $58.5 million in the third quarter; gross debt was $2.9 billion at quarter end
Barings BDC reported third quarter 2026 results for the period ended September 30, 2026. Net investment income fell to $27.2 million, or $0.26 per share, from $29.0 million, or $0.28 per share, in the prior quarter, while net asset value per share declined to $10.92 from $10.94, and the Board declared a $0.26 quarterly dividend.
Net investment income of $27.2 million, or $0.26 per share, versus $29.0 million, or $0.28 per share, in the quarter ended June 30, 2026
Net increase in net assets from operations of $24.6 million, or $0.24 per share, versus $18.3 million, or $0.18 per share, in the prior quarter
Net asset value per share of $10.92 as of September 30, 2026, down from $10.94; net debt-to-equity ratio rose to 1.24x from 1.18x
Quarterly dividend of $0.26 per share with a record date of December 2, 2026 and payment date of December 9, 2026; the company also priced a $396.3 million CLO on October 30, 2026
iRhythm reported third-quarter 2026 revenue of $221.6 million, up 14.9% from a year earlier, and raised its full-year 2026 revenue guidance to $890 million to $895 million. The GAAP net loss widened to $29.9 million, or $0.90 per share, from $5.2 million, or $0.16 per share, a year earlier, and the quarter included $49.8 million in litigation settlement charges.
Q3 2026 revenue of $221.6 million, up from $192.9 million in Q3 2025; gross margin was 74.2%
GAAP net loss of $29.9 million, or $0.90 per diluted share, versus a net loss of $5.2 million, or $0.16 per share, in Q3 2025
Litigation settlements of $49.8 million were recorded in the quarter
2026 revenue guidance raised to $890 million to $895 million, including about $16 million from the VitalConnect acquisition closed October 5, 2026
Nano Dimension reported third quarter 2026 revenue of $31.9 million, up 18.7% from a year earlier, while its net loss from continuing operations widened to $38.7 million from $29.5 million. The company also suspended its full year 2026 financial guidance and named Moshe Rozenbaum permanent Chief Executive Officer effective November 3, 2026, which shareholders will want to weigh alongside the pending sale of MarkForged, Inc. to Stratasys.
Q3 2026 revenue was $31.9 million, up from $26.9 million; Markforged contributed $18.6 million
Net loss from continuing operations was $38.7 million versus $29.5 million a year earlier, including a $22.1 million litigation, settlements and contingencies charge
Full year 2026 financial guidance has been suspended, and no third quarter earnings call will be held
Moshe Rozenbaum was appointed permanent CEO effective November 3, 2026, with a $600,000 base salary and a 1,000,000 RSU new-hire award
Northern Oil and Gas (NOG) reported third quarter 2026 record production of 156,239 Boe per day, up 19% from a year earlier, and raised its 2026 production guidance to 147,000 to 150,000 Boe per day. The company posted a GAAP net loss of $111.8 million, or $1.06 per diluted share, driven mainly by a non-cash mark-to-market loss of about $308.0 million on derivatives, while Adjusted EBITDA rose to $444.5 million. For shareholders, higher output and guidance are offset by a larger reported accounting loss and lower total revenues.
Production of 156,239 Boe per day, up 19% from Q3 2025; 2026 production guidance raised to 147,000 to 150,000 Boe per day from 143,000 to 148,000
GAAP net loss of $111.8 million ($1.06 per diluted share) versus a $129.1 million loss in Q3 2025, driven by a non-cash derivative loss of about $308.0 million
Oil and gas sales of $697.7 million, up from $482.2 million in Q3 2025; total revenues fell to $345.9 million from $556.6 million
Adjusted EBITDA of $444.5 million, up 11% from the second quarter of 2026; Free Cash Flow of $148.6 million
WillScot reported third quarter 2026 revenue of $601.3 million, up from $566.8 million a year earlier, and diluted EPS of $0.28 versus $0.24. Adjusted EBITDA fell to $233.6 million from $243.3 million, and its margin dropped to 38.8% from 42.9%. The company raised its 2026 revenue outlook to $2.340 billion but kept its Adjusted EBITDA outlook at $920 million, and it expects mid-single digit percentage Adjusted EBITDA growth in 2027.
Q3 2026 revenue $601.3 million vs. $566.8 million in Q3 2025; net income $51.6 million vs. $43.3 million
Adjusted EBITDA $233.6 million vs. $243.3 million; Adjusted EBITDA margin 38.8% vs. 42.9%; Adjusted diluted EPS $0.29 vs. $0.30
2026 outlook: revenue raised to $2.340 billion; Adjusted EBITDA maintained at $920 million; Net CAPEX outlook $400 million
Paid down $57 million of debt in the quarter; no debt maturities until August 2028; company expects leverage approaching 3.0x as it exits 2027
NerdWallet reported third quarter 2026 revenue of $239.6 million, up 11% from a year earlier, while GAAP net income fell 43% to $14.9 million, or $0.23 per diluted share. The company guided fourth quarter 2026 revenue to $191 million to $203 million, down 13% at the midpoint, and adjusted its full-year 2026 GAAP operating income expectation to $56 million to $62 million.
Q3 2026 revenue of $239.6 million, up 11% year over year; Consumer revenue $214.5 million, SMB revenue $25.1 million
Q3 GAAP income from operations of $19.4 million, down 44% from $34.4 million; diluted EPS $0.23 versus $0.34
Q4 2026 revenue guidance of $191 million to $203 million, down 13% at the midpoint; Q4 GAAP operating income guided to $2 million to $8 million
Cash and cash equivalents were $73.5 million at September 30, 2026, down from $120.6 million a year earlier
Rezolute reported first quarter fiscal 2027 results for the quarter ended September 30, 2026, with a net loss of $18.5 million, compared with $18.2 million a year earlier, and cash and investments of $90.0 million, down from $107.8 million at June 30, 2026. The company expects topline results from its Phase 3 upLIFT tumor HI study by mid-December 2026 and plans to submit a BLA for ersodetug in 2027, but the congenital HI sunRIZE study did not meet its primary endpoint, and FDA's support for a filing does not guarantee approval.
Net loss was $18.5 million, or $0.18 per share, versus $18.2 million, or $0.18 per share, a year earlier.
Cash, cash equivalents and marketable investments were $90.0 million at September 30, 2026, down from $107.8 million at June 30, 2026.
upLIFT tumor HI topline results are expected by mid-December 2026.
FDA recommended a BLA for congenital HI after a pre-BLA meeting, though the sunRIZE primary endpoint was not statistically significant.
Westwood Holdings Group reported third quarter 2026 revenue of $26.6 million, up from $25.3 million in the second quarter and $24.3 million a year earlier. Net income was $3.1 million, up from $1.5 million in the prior quarter but down from $3.7 million a year ago, after $1.7 million of one-time severance-related compensation expenses. The board also declared a $0.15 per share quarterly dividend, which shareholders may find relevant to their income expectations.
Total revenues were $26.6 million, versus $25.3 million in Q2 2026 and $24.3 million in Q3 2025.
Diluted EPS was $0.34, versus $0.17 in Q2 2026 and $0.41 in Q3 2025.
Non-GAAP Economic Earnings were $4.4 million, or $0.48 per share, versus $5.7 million, or $0.64 per share, in Q3 2025.
Quarterly dividend of $0.15 per share is payable January 4, 2027 to holders of record on December 1, 2026.
Puma Biotechnology reported third-quarter 2026 results, with total revenue up slightly to $55.1 million from $54.5 million while GAAP net income fell to $6.0 million from $8.8 million. The company raised its full-year 2026 net income outlook to $20–22 million from $17–20 million, but its total revenue outlook was narrowed, with the top end lowered to $227 million from $231 million.
Q3 2026 net product revenue was $54.1 million, up from $51.9 million in Q3 2025; royalty revenue was $1.0 million, down from $2.6 million.
Q3 2026 GAAP net income was $6.0 million, or $0.11 per diluted share, compared with $8.8 million, or $0.17 per diluted share, in Q3 2025.
Full-year 2026 net income outlook was raised to $20–22 million from $17–20 million; total revenue outlook is $224–227 million versus $224–231 million previously.
Cash, cash equivalents and marketable securities were $108.5 million at September 30, 2026.
Sweetgreen reported third-quarter fiscal 2026 revenue of $176.0 million, up 2.1%, with same-store sales down 6.4% and a net loss of $30.7 million, narrower than the prior year's $36.1 million. Adjusted EBITDA was a loss of $6.8 million, wider than the $4.4 million loss a year earlier, and the company updated its full-year fiscal 2026 outlook, including adjusted EBITDA between a $23.0 million and a $20.0 million loss. The filing does not state the prior outlook, so the change in guidance cannot be measured against it.
Q3 revenue $176.0 million, up 2.1%; same-store sales change (6.4)% versus (9.5)% a year earlier
Net loss $30.7 million versus $36.1 million; adjusted EBITDA loss $6.8 million versus $4.4 million
Restaurant-level profit margin 10.4%, down 270 basis points from 13.1%
Updated fiscal 2026 outlook: about (5.5)% same-store sales change, 11.0% to 11.5% restaurant-level profit margin, and about 10 net new restaurant openings
Arteris reported third quarter 2026 revenue of $25.8 million, up 48% from a year earlier, and issued estimated fourth quarter and updated full year 2026 guidance, including full year revenue of $98.5 million to $99.5 million. The GAAP net loss widened to $11.2 million, or $0.23 per share, from $9.0 million, while the non-GAAP net loss narrowed to $1.1 million from $3.8 million. The filing does not state prior guidance, so the change in outlook cannot be measured from this document.
Q3 2026 revenue of $25.8 million, up 48% year-over-year; ACV plus royalties of $103.8 million, up 39%
GAAP net loss of $11.2 million, or $0.23 per share, versus $9.0 million, or $0.21 per share, in Q3 2025
Non-GAAP net loss of $1.1 million, or $0.02 per share, versus $3.8 million, or $0.09 per share, a year earlier
FY 2026 guidance: revenue $98.5 million to $99.5 million; ACV plus royalties $103.0 million to $107.0 million; free cash flow $5.0 million to $9.0 million
Universal Electronics reported third-quarter 2026 results for the period ended September 30, 2026. Net sales fell slightly to $89.4 million from $90.6 million, while the GAAP net loss narrowed to $0.3 million from $8.3 million, and the company reiterated its fiscal 2026 adjusted non-GAAP EPS guidance of $0.45 to $0.65.
GAAP net loss was $0.3 million, or $0.03 per diluted share, versus a $8.3 million loss, or $0.62 per share, a year earlier.
Adjusted non-GAAP net income was $2.3 million, or $0.17 per diluted share, versus $1.1 million, or $0.08, a year earlier.
Net sales were $89.4 million versus $90.6 million; connected home rose to $33.8 million from $29.8 million, while home entertainment fell to $55.6 million from $60.8 million.
Fiscal 2026 adjusted non-GAAP diluted EPS guidance of $0.45 to $0.65 was reiterated, compared with $0.31 per share in fiscal 2025.
Citizens, Inc. (NYSE: CIA) reported a third-quarter 2026 net loss of $0.4 million, or $0.01 per diluted Class A share, compared with net income of $2.4 million, or $0.04, a year earlier. Total revenues rose to $65 million from $62.8 million, while higher future policy benefit reserves and lower reserve releases from matured endowments weighed on profit. For shareholders, the quarter shows premium growth alongside a return to a loss on a GAAP basis.
Q3 2026 total revenues were $65 million, up from $62.8 million; adjusted total revenues were $63.6 million, down from $64.1 million.
Net loss was $0.4 million in Q3 2026, versus $2.4 million net income in Q3 2025; adjusted net income was $1 thousand, versus $3.4 million.
Direct insurance premiums rose 7% to $50 million, with direct first year premiums up 9%.
Book value per Class A share was $4.37 at September 30, 2026, down from $4.49; adjusted book value per share excluding AOCI rose to $6.44 from $6.26.
Five9 reported third-quarter 2026 results on November 5, 2026. Revenue rose 13% to $323.3 million, while GAAP net income fell to $14.5 million from $18.0 million, and non-GAAP net income per diluted share rose to $0.82 from $0.78. The company also signed a definitive agreement to acquire Level AI for $325.0 million in cash, expected to close in Q4 2026, and its guidance excludes that deal.
Revenue rose 13% to $323.3 million; GAAP net income was $14.5 million, or $0.19 per diluted share, versus $18.0 million, or $0.21, a year earlier.
Non-GAAP net income per diluted share was $0.82 versus $0.78; adjusted EBITDA was $81.2 million, or 25.1% of revenue.
Full-year 2026 revenue guidance is $1.269 to $1.275 billion; fourth-quarter revenue guidance is $328.0 to $334.0 million.
Level AI acquisition for $325.0 million in cash, expected to close in Q4 2026, subject to customary closing conditions.
Green Plains reported third-quarter 2026 results on November 5, 2026, with net income attributable to the company of $85.4 million, or $1.03 per diluted share, up from $11.9 million, or $0.17, a year earlier. Revenue fell to $496.0 million from $508.5 million, while adjusted EBITDA rose to a record $118.0 million, including $65.4 million of Section 45Z tax credit value, and the company updated its 2026 guidance for that credit contribution. Shareholders should note that the prior-year figures were restated for a change in how the company accounts for 45Z credits.
Q3 2026 net income attributable to Green Plains was $85.4 million, or $1.03 per diluted share, versus $11.9 million, or $0.17, in Q3 2025.
Q3 2026 revenues were $496.0 million, down from $508.5 million, primarily due to the disposition of the Obion, Tennessee plant.
Adjusted EBITDA was $118.0 million, versus $52.6 million a year earlier, including $65.4 million of 45Z credit value net of discounts and other costs.
On October 29, 2026, the company executed an agreement to monetize $250 million to $325 million of 2026 45Z credits; full-year 2026 guidance for 45Z contribution is $230 million to $250 million of adjusted EBITDA.
KLX Energy Services reported third quarter 2026 revenue of $186 million, up 11% from the second quarter, and Adjusted EBITDA of $25 million, up 33%. Net loss widened to $15 million, or $(0.68) per diluted share, from $8 million in the prior quarter, and the company expects fourth quarter revenue of $172 million to $184 million. The results follow the closed Backstopped Rights Offering, which converted $87.8 million of debt to equity.
Revenue $185.6 million vs. $167.3 million in Q2 2026 and $166.7 million in Q3 2025
Net loss $(15.5) million, or $(0.68) per diluted share, vs. $(8.4) million, or $(0.41), in Q2 2026
Adjusted EBITDA $24.9 million vs. $18.7 million in Q2 2026; Adjusted EBITDA margin 13.4%
Q4 2026 revenue guidance of $172 million to $184 million; total liquidity $78.4 million at September 30, 2026
Rigel reported third quarter 2026 total revenues of $80.9 million, up from $69.5 million a year earlier, driven by net product sales of $72.3 million, including $6.6 million from newly launched VEPPANU. Net income fell to $13.2 million, or $0.65 per diluted share, from $27.9 million, or $1.46 per diluted share, as costs and expenses rose to $63.8 million from $41.0 million. The company raised its 2026 total revenue guidance at the low end, to $290 to $295 million, but lowered its net product sales range to $255 to $260 million.
Q3 2026 total revenues $80.9 million vs. $69.5 million in Q3 2025; net product sales up 13%
Q3 2026 net income $13.2 million ($0.65 diluted per share) vs. $27.9 million ($1.46) a year earlier
2026 total revenue guidance raised to $290 to $295 million from $285 to $295 million; net product sales guidance lowered to $255 to $260 million from $255 to $265 million
VEPPANU became commercially available August 13, 2026; cash and short-term investments were $99.3 million at September 30, 2026
Sarepta reported third quarter 2026 total revenues of $381.4 million, down $18.0 million (5%) from a year earlier, while GAAP operating loss narrowed to $9.0 million from $103.4 million. The company raised the low end of its full-year 2026 total net product revenue guidance by $50.0 million to $1.25 billion to $1.3 billion and lowered the high end of its expense guidance by $25.0 million to $800 million to $825 million.
Q3 2026 total revenues were $381.4 million, versus $399.4 million in Q3 2025, a decrease of $18.0 million.
Q3 2026 GAAP net loss was $28.5 million, or $(0.27) per diluted share, versus a $50.6 million loss a year earlier; non-GAAP net income was $15.6 million.
2026 total net product revenue guidance low end raised $50.0 million to $1.25 billion–$1.3 billion; combined non-GAAP R&D and SG&A expense guidance now $800 million–$825 million.
Cash, cash equivalents, restricted cash and investments were $998.7 million as of September 30, 2026.
EDAP TMS reported third quarter 2026 revenue of $9.8 million, up 26% from $7.8 million a year earlier, and a net loss of $4.5 million ($0.10 per share), narrower than the $5.9 million ($0.16 per share) loss in the prior-year quarter. The company narrowed its full-year 2026 revenue guidance to $50.0 million to $52.0 million from $50.0 million to $54.0 million, lowering the top of the range.
Q3 2026 revenue was $9.8 million, up 26% year over year; seven Focal One systems sold versus six a year earlier
Net loss was $4.5 million ($0.10 per share) versus $5.9 million ($0.16 per share) in Q3 2025, helped by a $2.6 million non-cash warrant fair value gain
Gross margin rose to 51.4% from 46.6%, while operating expenses increased to $12.8 million from $10.3 million
2026 revenue guidance narrowed to $50.0 million to $52.0 million from $50.0 million to $54.0 million
Lyft reported third-quarter 2026 revenue of $1.8 billion, up 8% year over year, and a net loss of $9.7 million, compared with net income of $46.1 million a year earlier. The company said the loss reflects $117.9 million in legal, tax and regulatory reserve changes and settlements, while Adjusted EBITDA rose 47% to $203.9 million and the company gave fourth-quarter 2026 Adjusted EBITDA guidance of $188 million to $213 million.
Q3 2026 revenue of $1.8 billion, up 8% year over year; $69.1 million of the $117.9 million reserve impact was recorded as a reduction to revenue
Net loss of $9.7 million, or $(0.03) per share, versus net income of $46.1 million in Q3 2025
Adjusted EBITDA of $203.9 million, up 47%; Q4 2026 outlook calls for Gross Bookings of $5.74 billion to $5.94 billion and Adjusted EBITDA of $188 million to $213 million
Mobia Medical reported third quarter 2026 revenue of $15.6 million, up 73% from $9.0 million a year earlier, and raised its full year 2026 revenue guidance to $57.0 million to $57.5 million. The net loss widened to $17.3 million from $11.4 million, although the per-share loss narrowed to $0.52 from $13.31 after the company's IPO increased its share count.
Q3 2026 revenue was $15.6 million, up from $9.0 million in Q3 2025; gross margin was 83.2% versus 79.6%.
Net loss was $17.3 million in Q3 2026, compared with $11.4 million in Q3 2025; operating expenses rose 71% to $31.5 million.
Full year 2026 revenue guidance was raised to $57.0 million to $57.5 million, from $54.0 million to $56.0 million previously.
Cash and cash equivalents totaled $160.7 million as of September 30, 2026.
El Pollo Loco reported third quarter 2026 results, with total revenue up to $126.3 million from $121.5 million and comparable restaurant sales up 5.0% system-wide. Net income fell to $6.9 million, or $0.23 per diluted share, from $7.4 million, or $0.25 a year earlier, as income from operations declined to $10.2 million from $11.5 million. The company updated its 2026 comparable restaurant sales growth expectation to approximately 4.5% and reiterated its adjusted EBITDA range of $68 million to $70 million.
Total revenue $126.3 million vs. $121.5 million; net income $6.9 million vs. $7.4 million
Adjusted net income $7.3 million, or $0.24 per diluted share, vs. $7.8 million, or $0.27 a year earlier
Adjusted EBITDA $17.1 million vs. $17.4 million; restaurant contribution margin 18.4% vs. 18.3%
2026 outlook: comparable restaurant sales growth of about 4.5%; adjusted EBITDA $68 million to $70 million reiterated
Fulgent Genetics reported third quarter 2026 revenue of $90.4 million, up about 8% from a year earlier, but swung to a GAAP loss of $13.2 million, or $(0.48) per share, from a loss of $(0.21) per share a year earlier. The company kept its full-year revenue guidance of $330.0-$340.0 million and improved its outlook for the full-year non-GAAP loss and cash, which it attributed to disciplined spending; the CFO also cited progress on a billing system issue. For shareholders, revenue growth is offset by larger losses in the quarter.
Q3 2026 revenue of $90.4 million versus $84.1 million a year earlier; GAAP loss of $13.2 million, or $(0.48) per share, versus $(0.21) per share
Non-GAAP loss of $2.4 million, or $(0.09) per share, compared with non-GAAP income of $4.5 million, or $0.15 per share, in Q3 2025
Full-year 2026 revenue guidance maintained at $330.0-$340.0 million; non-GAAP loss guidance set at approximately $46.0-$50.0 million
Cash, cash equivalents, restricted cash and marketable securities totaled $652.4 million at September 30, 2026
Akamai Technologies reported third quarter 2026 revenue of $1.1 billion, representing a 6% increase year-over-year. The company provided forward-looking revenue guidance, projecting 2027 total company revenue growth of 17% to 22% and 2028 total revenue to exceed $7.0 billion.
Third quarter revenue reached $1.1 billion, up 6% year-over-year.
Cloud Infrastructure Services revenue grew 34% year-over-year to $109 million.
GAAP net income per diluted share was $0.77, down 21% year-over-year.
Full-year 2027 total company revenue is projected to grow 17% to 22% year-over-year when adjusted for foreign exchange.
MasterBrand reported third-quarter 2026 results, with net sales of $1,036.8 million up from $698.9 million a year earlier, largely due to the American Woodmark acquisition, which closed May 28, 2026. The company posted a net loss of $9.2 million, compared with net income of $18.1 million in the prior-year quarter, and it expects a fourth-quarter adjusted diluted loss per share of $(0.12) to $(0.08). For shareholders, sales rose but profit fell, and the outlook supersedes the company's prior second-half 2026 outlook.
Net sales were $1,036.8 million, including $355.7 million from American Woodmark; legacy MasterBrand net sales fell 2.5% to $681.1 million.
Net loss was $(9.2) million, or $(0.05) per diluted share, versus net income of $18.1 million, or $0.14 per diluted share, a year earlier; adjusted diluted EPS was $0.10 versus $0.33.
Fourth-quarter 2026 outlook: net sales of $958 to $988 million and adjusted EBITDA of $38 to $48 million.
Full-year 2026 free cash flow is expected to be approximately breakeven; no share repurchases were made in the third quarter. Net debt was $1,091.1 million, a 4.3x ratio to trailing adjusted EBITDA.
Teradata reported third-quarter 2026 total revenue of $399 million, down 4% from $416 million a year earlier, and GAAP diluted EPS of $0.40 versus $0.42. It raised its full-year 2026 GAAP and non-GAAP EPS ranges, but expects fourth-quarter total revenue to fall 4% to 6% year-over-year.
Q3 2026 total revenue was $399 million versus $416 million; non-GAAP diluted EPS was $0.70 versus $0.72.
Total ARR rose to $1.512 billion, up 1% as reported; public cloud ARR rose 11% to $700 million.
Full-year 2026 non-GAAP diluted EPS raised to $2.86 to $2.90; full-year total revenue narrowed to -1% to flat year-over-year.
Fourth-quarter 2026 outlook: total revenue down 4% to 6% year-over-year; non-GAAP diluted EPS of $0.58 to $0.62.
Full House Resorts reported third-quarter 2026 revenue of $81.8 million, up 4.9% from $78.0 million a year earlier, driven mainly by American Place Casino. The net loss widened to $8.6 million, or $0.24 per diluted share, from $7.7 million, or $0.21, in the prior-year quarter, and Adjusted EBITDA was $14.6 million versus $14.8 million. Revenue grew while profit measures weakened, so the results point in mixed directions for shareholders.
Q3 2026 revenue rose 4.9% to $81.8 million from $78.0 million; American Place revenue increased 9.8%.
Net loss was $8.6 million, or $0.24 per diluted share, compared with $7.7 million, or $0.21, a year earlier.
Adjusted EBITDA was $14.6 million versus $14.8 million; Grand Lodge renovations and Chamonix initiatives are ongoing.
As of September 30, 2026, liquidity was $45.7 million, with $450.0 million in senior secured notes due 2028.
Castle Biosciences reported third-quarter 2026 revenue of $102.9 million, up from $83.0 million a year earlier, and raised its full-year 2026 revenue guidance to $385-395 million from $365-375 million. The company's net loss widened to $4.1 million, or $0.13 per share, from $0.5 million, or $0.02 per share, in the same period of 2025.
Q3 2026 revenue was $102.9 million, compared with $83.0 million in Q3 2025.
Q3 2026 net loss was $4.1 million, or $0.13 per share, versus $0.5 million, or $0.02 per share, a year earlier.
2026 total revenue guidance raised to $385-395 million from $365-375 million; positive Adjusted EBITDA expected for Q4 2026, full-year 2026 and full-year 2027.
Net cash provided by operations was $19.7 million in Q3 2026 versus $22.6 million a year earlier; cash and marketable investment securities totaled $277.7 million as of Sep. 30, 2026.
Artivion reported third-quarter 2026 revenue of $123.8 million, up 9% from $113.4 million a year earlier, but swung to a GAAP net loss of $7.9 million, or $0.16 per diluted share, from net income of $6.5 million, or $0.13 per diluted share, in the prior-year quarter. Adjusted EBITDA fell 8% to $22.5 million, and the company narrowed its full-year 2026 revenue and adjusted EBITDA guidance ranges.
Q3 2026 revenue of $123.8 million, up 9% on both GAAP and constant currency bases; On-X grew 13% in constant currency.
Q3 2026 GAAP net loss of $(7.9) million, or $(0.16) per diluted share, versus net income of $6.5 million, or $0.13, in Q3 2025.
Adjusted EBITDA declined 8% to $22.5 million from $24.6 million.
FY 2026 revenue guidance narrowed to $484 million to $492 million from $480 million to $496 million; adjusted EBITDA guidance narrowed to $93 million to $98 million from $92 million to $99 million.
Pulse Biosciences reported third quarter 2026 revenue of $0.4 million, up from $0.1 million a year earlier, while its GAAP net loss widened to $23.1 million from $19.4 million. The company also said it completed enrollment in its U.S. pivotal NANOPULSE-AF study and ended the quarter with $189.2 million in cash, cash equivalents, and marketable securities, after raising $95.8 million through its ATM programs.
GAAP net loss was $23.1 million, or $0.32 per share, versus $19.4 million, or $0.29 per share, a year earlier.
Cash, cash equivalents, and marketable securities totaled $189.2 million as of September 30, 2026, compared with $101.6 million on June 30, 2026.
NANOPULSE-AF pivotal study completed enrollment with 169 evaluable patients, three months ahead of the original plan.
Health Catalyst reported third-quarter 2026 revenue of $56.3 million, down 26% from $76.3 million a year earlier, and Adjusted EBITDA of $779 thousand, versus $12.0 million. GAAP net income was $40.5 million, compared with a $22.2 million loss, largely because of a $65.9 million gain on the sale of its Vitalware business, which closed on July 31, 2026. The company reaffirmed its full-year 2026 guidance of $246 million to $249 million in revenue and $18 million to $18.5 million in Adjusted EBITDA.
Q3 2026 revenue was $56.3 million, down from $76.3 million; gross margin was 31%, down from 39%.
GAAP net income was $40.5 million, or $0.53 per diluted share, versus a net loss of $22.2 million; the result includes a $65.9 million gain on the Vitalware sale.
Adjusted EBITDA was $779 thousand, down from $12.0 million a year earlier.
Full-year 2026 guidance was reaffirmed: total revenue of $246 million to $249 million and Adjusted EBITDA of $18 million to $18.5 million.
Arlo Technologies reported third-quarter 2026 results for the period ended September 27, 2026, with revenue of $149.2 million versus $139.5 million a year earlier and GAAP diluted EPS of $0.01 versus $0.06. Non-GAAP diluted EPS rose to $0.24 from $0.16, and the company authorized a new stock repurchase program of up to $100 million through December 31, 2028. The company also issued fourth-quarter 2026 revenue guidance of $137 million to $147 million.
Q3 2026 revenue of $149.2 million, up from $139.5 million a year earlier and down from $155.9 million in the prior quarter
Subscriptions and services revenue of $96.0 million, up 20.1% year over year; GAAP net income of $0.9 million versus $6.9 million a year earlier
Non-GAAP diluted EPS of $0.24 versus $0.16 a year earlier; adjusted EBITDA of $26.9 million
New buyback of up to $100 million through December 31, 2028; Q4 2026 revenue guidance of $137 million to $147 million, GAAP EPS of $(0.03) to $0.03
Solventum reported third-quarter 2026 net sales of $1.9 billion, a 7.0 percent decrease on a reported basis due to prior-quarter advance orders placed ahead of ERP cutovers. Despite the sales decline and a GAAP net loss of $12 million, the company raised its full-year adjusted diluted EPS guidance to a range of $7.20 to $7.30 and expects organic sales growth toward the high end of its +2.5% to +3.0% range.
Q3 2026 net sales were $1.9 billion, reflecting a 7.0% reported decrease and a 2.8% organic decrease.
GAAP diluted earnings per share was $(0.07), while adjusted diluted earnings per share was $1.45.
Full-year adjusted EPS guidance was raised to $7.20 to $7.30 from the prior range of $7.10 to $7.20.
Fidus Investment Corporation reported third quarter 2026 results, with total investment income rising 23.2% to $45.9 million and net investment income rising 21.7% to $21.1 million, or $0.54 per share. Net increase in net assets from operations fell to $20.3 million, or $0.52 per share, from $0.54 a year earlier, after a $10.9 million net realized loss on investments. The board also declared fourth quarter dividends totaling $0.54 per share, payable December 29, 2026.
Total investment income was $45.9 million, up from $37.3 million; net investment income per share was $0.54, up from $0.49.
Net increase in net assets from operations was $20.3 million, or $0.52 per share, down from $0.54 per share, including a $10.9 million net realized loss on investments.
Net asset value was $19.47 per share as of September 30, 2026, compared with $19.55 at December 31, 2025.
Fourth quarter dividends are a $0.43 base dividend and a $0.11 supplemental dividend per share, payable December 29, 2026, to holders of record on December 18, 2026.
Century Aluminum reported third quarter 2026 net income attributable to Century of $302.6 million, or $2.89 per diluted share, up from $249.3 million, or $2.39, in the second quarter, on net sales of $961.2 million. Adjusted EBITDA attributable to Century was $331.6 million, and the company expects fourth quarter 2026 Adjusted EBITDA of $275 million to $300 million, below the third quarter level.
Q3 2026 net sales of $961.2 million, up $209.1 million from Q2 2026, driven by higher shipments after the Grundartangi Line 2 restart
Q3 2026 diluted EPS of $2.89 versus $2.39 in Q2 2026; adjusted EPS of $2.58 versus $2.46
Q4 2026 Adjusted EBITDA outlook of $275 million to $300 million
Liquidity of $1,161.5 million at September 30, 2026, including $713.0 million in cash and cash equivalents
PRA Group reported third quarter 2026 results on November 5, 2026, with net income attributable to the company of $15 million, or $0.39 per diluted share, compared with a loss of $407.7 million ($10.43 per share) a year earlier that included a $413 million goodwill impairment. Total portfolio revenue fell 8% to $285 million, and cash collections were $536 million, slightly below the prior-year quarter, so the profit improvement came mainly from lower operating expenses.
Total portfolio revenue fell 8% to $285 million, from $310 million in Q3 2025, mainly due to lower changes in expected recoveries.
Net income attributable to PRA Group was $15 million, or $0.39 per diluted share, versus a loss of $407.7 million in Q3 2025.
Operating expenses fell to $200 million from $627 million, which included the $413 million goodwill impairment in the prior-year quarter.
In October 2026 the company issued $400 million of senior notes due 2033.
aTyr Pharma reported a third-quarter 2026 net loss of $18.3 million, or $7.43 per share, down from $25.7 million, or $10.60 per share, a year earlier, with no revenue compared with $190,000 in the prior-year quarter. Cash, cash equivalents, restricted cash and investments totaled $50.3 million at September 30, 2026, down from $80.9 million at December 31, 2025, and the company says this funds operations into late 2028. The company is prioritizing strategic partnerships to advance the proposed Phase 3 study of efzofitimod in pulmonary sarcoidosis, which shifts how that program will be funded.
Q3 2026 net loss $18.3 million ($7.43 per share) vs. $25.7 million ($10.60 per share) in Q3 2025
Q3 2026 revenue was zero vs. $190,000 in Q3 2025; R&D expenses $10.4 million and G&A expenses $8.3 million
Cash and investments of $50.3 million at September 30, 2026, vs. $80.9 million at December 31, 2025; runway into late 2028
Reached FDA alignment on the Phase 3 protocol and is prioritizing strategic partnerships and/or licensing arrangements to advance the study
Dropbox reported third-quarter 2026 revenue of $637.3 million, representing a 0.5% year-over-year increase, alongside GAAP net income of $116.1 million. The company also announced a planned $350.0 million cash acquisition of Tigris Data and the launch of DBX Agent Cloud to expand into AI infrastructure.
Total revenue was $637.3 million for the quarter ended September 30, 2026, up 0.5% year-over-year.
GAAP net income was $116.1 million, and non-GAAP net income reached $197.8 million.
Announced an agreement to acquire Tigris Data for approximately $350.0 million in cash.
Total annual recurring revenue reached $2.555 billion, an increase of 0.8% year-over-year.
NMI Holdings reported third-quarter 2026 net income of $93.5 million, or $1.23 per diluted share, for the quarter ended September 30, 2026. That was down from $105.8 million, or $1.38 per share, in the second quarter, but up slightly from $1.22 per share in the third quarter of 2025, while total revenue of $187.6 million was roughly flat sequentially and up from $178.7 million a year earlier.
Diluted EPS was $1.23 versus $1.38 in Q2 2026 and $1.22 in Q3 2025; adjusted diluted EPS was $1.23.
Insurance claims and claim expenses were $29.1 million, with a loss ratio of 18.7% versus 8.3% in Q2 2026 and 12.3% in Q3 2025.
Book value per share excluding unrealized gains and losses was $38.13, up 14% from $33.32 a year earlier.
The company repurchased 626,383 shares for $27.1 million in the quarter and has bought back $435 million since the program began.
Alpha and Omega Semiconductor reported results for its fiscal first quarter of 2027, ended September 30, 2026. Revenue rose 4.3% from the June quarter to $177.8 million but fell 2.6% from a year earlier, and the GAAP net loss was $6.1 million, or $0.20 per diluted share, compared with a $2.1 million loss a year earlier. The company expects fiscal second-quarter revenue of approximately $180 million, plus or minus $10 million, so shareholders face sequential improvement alongside a year-over-year decline in profit and sales.
Revenue was $177.8 million, up 4.3% from $170.4 million in the June 2026 quarter and down 2.6% from $182.5 million a year earlier.
GAAP net loss was $6.1 million, or $0.20 per diluted share, versus a $13.1 million loss ($0.43) in the June quarter and a $2.1 million loss ($0.07) a year earlier.
Non-GAAP net loss was $2.1 million, or $0.07 per share, compared with non-GAAP net income of $4.2 million ($0.13 per share) a year earlier.
Fiscal Q2 guidance: revenue of approximately $180 million, plus or minus $10 million, and GAAP gross margin of 25.1%, plus or minus 1%.
Viasat reported second quarter fiscal year 2027 revenue of $1.2 billion, up 3% year-over-year, alongside a net loss of $129 million. The company experienced strong growth in its Defense and Advanced Technologies segment, offset by declines in Communication Services, while generating $78 million in free cash flow.
Honest Company reported third quarter 2026 revenue of $84.6 million, down 8.6% from a year earlier, while Organic Revenue, which excludes exited operations, rose 9.2% to $79.3 million. Net income rose to $91.3 million, but it includes an $89.4 million discrete income tax benefit, and the company raised its full-year 2026 outlook and authorized a new $30 million share repurchase program.
Q3 2026 revenue was $84.6 million, down 8.6%; Organic Revenue was $79.3 million, up 9.2%.
Net income was $91.3 million, including an $89.4 million income tax benefit; Underlying Adjusted Net Income was $3.1 million.
Full-year 2026 revenue outlook was raised to $322 million to $325 million, from $319 million to $325 million.
Board approved a new share repurchase program of up to $30 million on October 30, 2026.
Elutia reported third-quarter 2026 net sales of $1.1 million, up 20.4% from $0.9 million a year earlier. Its net loss narrowed to $1.3 million from $3.9 million, but that improvement came from $5.2 million of income from discontinued operations, while the loss from continuing operations widened to $6.5 million from $1.0 million. The company also said it received $26 million in funding in 2026 and plans to submit NXT-41x to the FDA in the fourth quarter of 2026.
Net sales were $1.1 million versus $0.9 million, an increase of 20.4%; cardiovascular sales grew 20%.
Net loss from continuing operations was $6.5 million versus $1.0 million; net loss was $1.3 million versus $3.9 million.
Income from discontinued operations was $5.2 million versus a loss of $2.8 million a year earlier.
Cash and cash equivalents were $29.1 million at September 30, 2026, excluding an $8 million Boston Scientific holdback received October 1, 2026.
Kratos reported third quarter 2026 revenue of $471.8 million, up 35.7% from a year earlier, and raised its adjusted EBITDA guidance for fiscal 2026 while tightening its revenue range. GAAP results weakened, with a net loss of $0.2 million compared with net income of $8.7 million a year earlier, and the company issued an initial 2027 forecast that assumes a continuing resolution into early 2027.
Q3 2026 revenue $471.8 million vs. $347.6 million in Q3 2025; organic growth 23.2%
GAAP net loss of $0.2 million (EPS $0.00) vs. net income of $8.7 million ($0.05 per share) in Q3 2025; adjusted EPS $0.24 vs. $0.14
FY2026 guidance: revenue $1,780 - $1,810 million and adjusted EBITDA $176 - $180 million
Initial FY2027 forecast: revenue $2,100 - $2,200 million and adjusted EBITDA $230 - $240 million; Q1 2027 expected to be the lightest quarter
The Joint Corp. reported third quarter 2026 revenue of $13.6 million, up 1% from the prior year, and a consolidated net loss of $117,000 compared with net income of $855,000 a year earlier. Net income from continuing operations rose to $1.5 million, but the company lowered its full-year 2026 system-wide sales guidance, kept Adjusted EBITDA guidance unchanged, and its board authorized an additional $5.0 million for stock repurchases.
Q3 2026 revenue was $13.6 million, compared with $13.4 million in Q3 2025; system-wide sales fell 3.1% to $123.3 million.
Consolidated net loss was $117,000 (EPS $(0.01)), versus net income of $855,000 in Q3 2025; continuing operations net income was $1.5 million, versus $290,000.
2026 system-wide sales guidance was cut to $508 million to $512 million from $519 million to $552 million; Adjusted EBITDA guidance of $12.5 million to $13.5 million was unchanged.
On November 3, 2026, the board authorized an additional $5.0 million for stock repurchases, running until November 4, 2027; the company repurchased $3.8 million of stock in Q3 2026.
Doximity reported fiscal second-quarter revenue of $174.5 million, up 4% from a year earlier, but net income fell to $34.7 million from $62.1 million and adjusted EBITDA declined 12% to $88.9 million. The company also gave fiscal third-quarter and updated full-year fiscal 2027 guidance, which shareholders can compare against these results.
Revenue of $174.5 million versus $168.5 million, up 4% year-over-year
Net income of $34.7 million versus $62.1 million; diluted EPS of $0.18 versus $0.31
Adjusted EBITDA of $88.9 million versus $100.8 million, down 12%; margin 50.9% versus 59.8%
Fiscal 2027 revenue guidance of $678 million to $683 million and adjusted EBITDA of $317 million to $325 million; third-quarter revenue guidance of $195 million to $196 million
MannKind reported third quarter 2026 total revenues of $101.9 million, up 24% from a year earlier, mainly due to Furoscix, acquired from scPharma in October 2025. The company posted a net loss of $23.2 million, or $0.07 per share, compared with net income of $8.0 million, or $0.03 per share, in the prior-year quarter, as selling, general and administrative expenses rose to $61.4 million. For shareholders, revenue growth came with higher costs and a loss, and the company reported $96.6 million in cash, cash equivalents and investments as of September 30, 2026.
Total revenues were $101.9 million, up from $82.1 million in Q3 2025; Furoscix contributed $22.4 million.
Net loss was $23.2 million ($0.07 per share), compared with net income of $8.0 million ($0.03 per share) a year earlier.
Selling, general and administrative expenses were $61.4 million, up 111% from $29.1 million; commercial cost of goods sold was $11.2 million vs. $4.5 million.
Furoscix ReadyFlow shipments began in mid-September, and about 75% of weekly Furoscix shipments had transitioned to ReadyFlow by late October.
Blink Charging reported third-quarter 2026 revenue of $18.4 million, down 32.0% from a year earlier, and lowered its full-year 2026 revenue guidance to $78 million to $81 million from $83 million to $90 million. The company also reported its first positive quarterly adjusted EBITDA of $0.2 million, while GAAP net loss was $6.7 million, and it named CEO Michael Battaglia Chairman of the Board.
Q3 2026 total revenue of $18.4 million, down 15.1% from the second quarter and 32.0% from Q3 2025
Full-year 2026 revenue guidance cut to $78 million to $81 million from $83 million to $90 million
Adjusted EBITDA of $0.2 million versus a $(7.3) million loss in Q3 2025; GAAP net loss of $6.7 million, or $(0.05) per diluted share
Cash and cash equivalents of approximately $30.5 million and no debt as of September 30, 2026
Biodesix reported third-quarter 2026 revenue of $24.0 million, up 10% year over year, and a net loss of $8.0 million, narrowed 8% from a year earlier. The company revised its full-year 2026 revenue guidance to $101 million to $103 million, and CEO Scott Hutton said growth was below the company's expectations, citing sales team, seasonality and development services timing issues.
Total revenue $24.0 million in Q3 2026, up 10%; Diagnostic Testing revenue $23.0 million, up 16%
Test volumes rose 24% to 19,400; gross margin was 81%, flat year over year
Net loss $8.0 million vs. $8.7 million a year earlier; Adjusted EBITDA loss $3.9 million vs. $4.6 million
Full-year 2026 revenue guidance revised to $101 million to $103 million
Voyager Therapeutics reported third quarter 2026 results, with collaboration revenue down sharply from a year earlier while its net loss narrowed. The company said its cash runway now extends into the second quarter of 2028, and it expects tau PET imaging data from its VY7523 trial in the fourth quarter of 2026.
Collaboration revenue was $4.0 million for Q3 2026, down from $13.4 million in Q3 2025, mainly due to lower Neurocrine collaboration revenue.
Net loss was $24.7 million, or $0.40 per share, versus $27.9 million, or $0.47 per share, in Q3 2025.
Research and development expenses fell to $24.4 million from $35.9 million; general and administrative expenses fell to $6.1 million from $8.1 million.
Cash, cash equivalents and marketable securities were $132.1 million as of September 30, 2026.
Conduent reported third quarter 2026 results with revenue of $534 million, down from $605 million a year earlier, while adjusted EBITDA from continuing operations rose to $36 million from $31 million. GAAP net loss from continuing operations was $(40) million, compared with $(42) million a year earlier, and GAAP diluted EPS from continuing operations was $(0.27) in both periods. The company reaffirmed its full-year 2026 outlook of $2.15 billion to $2.25 billion in revenue and $140 million to $170 million in adjusted EBITDA.
Q3 2026 revenue was $534 million versus $605 million in Q3 2025, an 11.7% decline.
Adjusted EBITDA margin was 6.7%, up 160 basis points from 5.1%; the company identified $106 million of a $120 million cost-savings target.
Completed the sale of its Public Transit business to Modaxo for $164 million; the Tolling business sale is expected to close by year-end.
Completed $447 million in revolving credit commitments maturing in May 2029; Q3 operating cash flow was $(107) million versus $(39) million a year earlier.
AGNT, Inc. reported third-quarter 2026 revenue of $1.4 billion, up 6% from $1.3 billion a year earlier, but posted a net loss of $4.3 million, or $0.03 per diluted share, compared with net income of $3.5 million, or $0.02 per share, in the prior-year period. Adjusted EBITDA fell 3% to $17.1 million, and the company set Fourth Quarter 2026 and full-year 2026 outlooks that include a Q4 adjusted EBITDA range of $(7) million to $0 million.
Q3 2026 revenue rose 6% to $1.4 billion; net loss was $4.3 million versus net income of $3.5 million a year earlier
Adjusted EBITDA was $17.1 million, down 3% from $17.7 million; operating cash flow was $18.2 million versus $28.9 million
Full-year 2026 outlook: revenue of $4.85 billion to $5.05 billion and adjusted EBITDA of $40 million to $47 million
Board declared a $0.05 per share dividend payable December 4, 2026 to holders of record on November 20, 2026
Gold.com reported fiscal first quarter 2027 results for the three months ended September 30, 2026. Revenue fell 11% year over year to $3.265 billion, while net income attributable to the Company rose to $1.6 million, or $0.05 per diluted share, from a loss of $0.9 million a year earlier. The board also declared a quarterly cash dividend of $0.20 per share, maintaining its current dividend program.
Revenue was $3.265 billion, down 11% from $3.681 billion a year earlier and down 35% from $5.005 billion in the June 2026 quarter.
Net income attributable to the Company was $1.6 million, or $0.05 per diluted share, compared with a loss of $0.9 million, or $0.04 per share, a year earlier.
Non-GAAP EBITDA was $17.4 million, up 22% from $14.3 million a year earlier, but down 38% from $28.2 million in the June 2026 quarter.
Quarterly cash dividend of $0.20 per share is payable December 2, 2026, to stockholders of record as of November 19, 2026.
NorthWestern Energy reported third-quarter 2026 net income of $30.7 million, or $0.50 per diluted share, down from $38.2 million, or $0.62, a year earlier, mainly due to a $6.1 million net loss tied to its added Colstrip Units 3 and 4 interests, plus higher depreciation and interest expense. The company affirmed its 2026 non-GAAP earnings guidance of $3.68 to $3.83 per diluted share, but the guidance is standalone and will no longer apply if the pending Black Hills merger closes, which the company expects by year-end 2026.
Q3 2026 net income $30.7 million ($0.50 per diluted share) vs. $38.2 million ($0.62) in Q3 2025; total revenues rose to $423.8 million from $387.0 million
Adjusted non-GAAP diluted EPS was $0.58 vs. $0.79 a year earlier; 2026 guidance of $3.68 to $3.83 per diluted share affirmed
Merger with Black Hills expected to close by year-end 2026, pending a Montana Public Service Commission final order
Quarterly dividend of $0.67 per share payable December 1, 2026, to holders of record on November 17, 2026 (previously set for December 31 and December 15)
Hudson Pacific reported third quarter 2026 results on November 5, 2026. Total revenue fell to $180.9 million from $186.6 million, and the net loss attributable to common stockholders widened to $218.1 million, or $3.38 per diluted share, from $136.5 million, or $2.12 per share, mainly due to non-cash impairments and a loss on the sale of office properties. Core FFO per diluted share rose to $0.28 from $0.26, and the company raised and narrowed its full-year 2026 Core FFO outlook to $1.15 to $1.21 per share from $1.12 to $1.20.
Core FFO of $18.6 million, or $0.28 per diluted share, for the quarter, compared with $16.7 million, or $0.26, a year earlier
Total revenue of $180.9 million, down from $186.6 million, mainly due to asset dispositions
Net loss of $218.1 million, or $3.38 per diluted share, compared with $136.5 million, or $2.12, a year earlier
Full-year 2026 Core FFO outlook of $1.15 to $1.21 per diluted share, up from $1.12 to $1.20; pro forma liquidity of $840 million
Tronox reported third quarter 2026 revenue of $827 million, up 18% from a year earlier, and a net loss of $55 million, or $0.34 per diluted share, versus a $0.63 loss a year earlier. Adjusted EBITDA rose 36% to $101 million, but the company now expects full-year 2026 free cash flow to be a use of $25-50 million, updated from previous expectations, citing Middle East conflict-driven raw material costs and weaker volumes.
Q3 2026 revenue of $827 million, up 18% year over year and down 5% from Q2 2026; net loss of $55 million, or $0.34 per diluted share, compared with $0.63 a year earlier
Adjusted EBITDA of $101 million, up 36% year over year, with an adjusted EBITDA margin of 12.2%
Q4 2026 Adjusted EBITDA expected at $80-$90 million; full-year 2026 free cash flow expected to be a use of approximately $25-50 million
Net leverage ratio of 10.5x on a trailing twelve-month basis at September 30, 2026; available liquidity of $509 million
Perma-Fix reported third quarter 2026 revenue of $17.9 million, up slightly from $17.5 million a year earlier, driven by higher Services Segment revenue. Net loss widened to $3.5 million, or $(0.16) per share, from $1.8 million, or $(0.10) per share, as Treatment Segment revenue fell and gross profit dropped to $552,000. The company's 10-Q states that recurring losses and negative operating cash flows continue to raise substantial doubt about its ability to continue as a going concern.
Revenue was $17.9 million versus $17.5 million in Q3 2025; Services Segment rose to $6.3 million from $4.4 million, while Treatment Segment fell to $11.6 million from $13.1 million
Net loss was $3.5 million, or $(0.16) per basic share, versus $1.8 million, or $(0.10) per share, in Q3 2025
Gross profit was $552,000 versus $2.6 million a year earlier; Treatment Segment posted a gross loss of $225,000
At September 30, 2026, PNC Liquidity was $19.9 million; management concluded substantial doubt about going concern has not been alleviated
MDU Resources reported third-quarter 2026 net income of $14.0 million, down from $18.4 million a year earlier, and diluted EPS of $0.07 versus $0.09. Revenue rose to $347.8 million from $315.1 million, and the company reaffirmed 2026 EPS guidance of $0.93 to $1.00. Shareholders also learned that the board made a positive final investment decision on the Bakken East Pipeline, with an estimated capital investment of $2.8 billion to $3.1 billion.
Net income was $14.0 million versus $18.4 million; diluted EPS was $0.07 versus $0.09, and adjusted EPS was $0.08 versus $0.09.
Operating revenues were $347.8 million, up from $315.1 million in the third quarter of 2025.
Electric utility net income rose to $26.5 million from $21.5 million, while the natural gas distribution segment posted a $20.7 million seasonal loss and pipeline net income fell to $13.1 million from $16.8 million.
The Bakken East Pipeline decision was made Sept. 30, 2026; the company's estimated capital range is $2.8 billion to $3.1 billion, and first-phase completion is expected in late 2029.
Investors Title reported third-quarter 2026 results on November 5, 2026. Revenue rose 12.1% to $81.9 million, but net income fell to $9.4 million, or $4.97 per diluted share, from $12.2 million, or $6.45, a year earlier, as net investment losses and higher claims provisions weighed on earnings. For the first nine months, net income rose 8.9% to $30.1 million, or $15.91 per diluted share.
Q3 revenue was $81.9 million, up from $73.0 million, while operating expenses rose 21.7% to $70.5 million.
Q3 diluted EPS was $4.97, down from $6.45; net investment losses were $1.7 million versus gains of $2.1 million a year earlier.
Nine-month net income rose 8.9% to $30.1 million, or $15.91 per diluted share, compared with $14.59 a year earlier.
Adjusted income before income taxes (non-GAAP) was $13.1 million in Q3, compared with $13.0 million in the prior-year quarter.
ScanSource reported first-quarter fiscal 2027 net sales of $962.3 million, up 30.1% year over year, with GAAP net income down 56.3% to $8.7 million, or $0.42 per diluted share. The company raised its full-year fiscal 2027 outlook for net sales and adjusted EBITDA to include the MicroAge acquisition, which closed on September 1, 2026.
Net sales were $962.3 million, up 30.1%; gross profit margin fell to 12.2% from 14.5%.
GAAP diluted EPS was $0.42 versus $0.89 a year earlier; non-GAAP diluted EPS was $0.86 versus $1.06.
FY27 outlook raised to net sales of $3.8 billion to $4.0 billion and adjusted EBITDA of $175 million to $185 million, up from $158 million to $165 million.
Operating cash flow was negative $42.3 million, mainly from working capital investment; higher bad debt expense of about $4.5 million was tied mostly to Brazil.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.